Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Tyagi, Rakesh K.
- The Constitutive Androstane Receptor (CAR): A Nuclear Receptor in Health and Disease
Abstract Views :371 |
PDF Views:8
Authors
Amit K. Dash
1,
Ashutosh S. Yende
1,
Sudhir Kumar
1,
Shashi Kala Singh
1,
Deepak Kotiya
1,
Manjul Rana
1,
Rakesh K. Tyagi
1
Affiliations
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi-110067, IN
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi-110067, IN
Source
Journal of Endocrinology and Reproduction, Vol 18, No 2 (2014), Pagination: 59-74Abstract
Constitutive Androstane Receptor (CAR, NR1I3), a member of the nuclear receptor superfamily of transcription factors, has emerged as one of the key regulators of the drug and xenobiotic metabolism. The unique feature that separates CAR from other members of the superfamily is that it remains active in the absence of ligand and is further regulated by activators. From its first isolation in 1994, a number of studies related to its distribution, characteristics, functions, and relation to other members of the superfamily have been conducted that place it centrally, governing many key events of the body. Human CAR is expressed relatively higher in liver and epithelial cells of the small intestine villi and less in heart, muscle, kidney, brain and lung. Though there are some controversies regarding its subcellular localization in different cell lines, in general, the subcellular localization of CAR is reported to be predominantly cytoplasmic, in complex with co-chaperone partners HSP90 and CCRP (cytoplasmic CAR retention protein). To execute transcription functions, nuclear translocation is a prerequisite event for a NR, including CAR. In this context, existence of two pathways is suggested, i) direct mechanism of action; and ii) indirect mechanism of action that is governed via nuclear translocation of CAR. Additionally, existence of species-specific differences in its modulation with ligands acting either as an agonist, antagonist or inverse agonist is also apparent. Like the other xenobiotic receptor PXR, CAR also functions as an alternative 'xenosensor' to defend the body against persistent chemical insults. It responds to diverse array of chemically distinct compounds, including endobiotics and xenobiotics, to regulate the clearance of noxious chemicals and toxic metabolites in liver and intestine via induction of genes involved in their metabolism. The usefulness of targeting CAR in metabolic diseases including bilirubinemia, obesity, type 2 diabetes mellitus, atherosclerosis, preeclampsia, hypertension, cholestasis and also in liver cancer is being extensively studied in animal models. However, to determine the human relevance it requires further investigation. Though a large number of natural and synthetic compounds act as modulators of CAR, designing new derivatives with defined therapeutic benefit need to be investigated. The purpose of this review is to highlight the general aspects of nuclear receptor CAR, its mechanism of action and importance in human health and disease.Keywords
Nuclear Receptors, Transcription Factors, Constitutive Androstane Receptor, Xenosensor, Drug Metabolism, Metabolic Diseases, Sub-Cellular Localization, Cancer.References
- Abass K, Lamsa V, Reponen P, Kublbeck J, Honkakoski P, Mattila S, Pelkonen O, Hakkola J. (2012) Characterization of human cytochrome P450 induction by pesticides. Toxicology 294:17 - 26.
- Alnouti Y, Klaassen CD. (2008) Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther. 324: 612-21.
- Auerbach SS, Ramsden R, Stoner MA, Verlinde C, Hassett C, Omiecinski C. (2003) Alternatively spliced isoforms of the human constitutive androstane receptor. Nucl Acid Res. 31: 3194-207.
- Baes M, Gulick T, Choi H-S, Martinoli MG, Simha D, Moore DD. (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol. 14: 1544-52.
- Burk O, Arnold KA, Geick A, Tegude H, Eichelbaum M. (2005) A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem. 386:503-13.
- Burk O, Piedade R, Ghebreghiorghis L, Fait JT, Nussler AK, Gil JP, B Windshugel B, Schwab M. (2012) Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoforms. Br J Pharmacol. 167:666-81.
- Burris TP, Busby S, Griffin PR. (2012) Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity. Chem Bio. 19: 51-59.
- Catz C, Yaffe SJ. (1962) Pharmacological modification of bilirubin conjugation in the newborn. Am J Dis Child. 104:516-17.Cerveny L, Svecova L, Anzenbacherova E, Vrzal R, Staud F, Dvorak Z, Ulrichova J, Anzenbacher P, Paveket P. (2007) Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane x receptor pathways. Drug Metab Dispos. 35: 1032-41.
- Chakraborty S, Kanakasabai S, Bright JJ. (2011) Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. Br J Cancer 104:448-59.
- Chang TKH. (2009) Activation of pregnane x receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines. AAPS J. 11: 590-601.
- Chiang JYL. (2009) Xenobiotic receptor cofactors and coregulators. In: Xie W (Ed), Nuclear Receptors in Drug Metabolism. pp167-68. John Wiley & Sons, Inc.
- Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, Moore DD. (1997) Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem. 272: 23565-71.
- Columbano A, Ledda-Columbano GM, Pibiri M, Cossu C, Menegazzi M, Moore DD, Huang W, Tian J, Locker J. (2005) Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 42:1118-26.
- Dau PT, Sakai H, Hirano M, Ishibashi H, Tanaka Y, Kameda K, Fujino T, Kim E-Y, Iwataet H. (2013) Quantitative analysis of the interaction of constitutive androstane receptor with chemicals and steroid receptor coactivator 1 using surface plasmon resonance biosensor systems: a case study of the baikal seal (Pusa sibirica) and the mouse. Toxicol Sci. 131:116-27.
- DeKeyser JG, Stagliano MC, Auerbach SS, Prabhu KS, Jones AD, Omiecinski CJ. (2009) Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2. Mol Pharmacol. 75:1005-13.
- Ding X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL (2006) Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferatoractivated receptor gamma coactivator-1alpha. J Biol Chem. 281: 26540-51.
- Doherty MM, Charman WN. (2002) The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clin Pharmacokinetics 41: 235-253.
- Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, Wakil SJ, Stevens RD, Ilkayeva O, Newgard CB, Chan L, Moore DD. (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA. 106:18831-36.
- Duckitt K, Harrington D. (2005) Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ. 330:565.
- Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski CJ, LeCluyse EL, Negishi M, Wang H. (2007) Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther. 320:72-80.
- Ferguson SS, Chen Y, Le Cluyse EL, Negishi M. Goldstein JA. (2005) Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4 alpha. Mol Pharmacol. 68: 747-57.
- Fisher CD, Augustine LM, Maher JM, Nelson DM, Slitt AL, Klaassen CD, Lehman-McKeeman LD, Cherrington NJ. (2007) Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2. Drug Metab Dispos. 35: 995-1000.
- Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD. (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 395: 612-15.
- Fukumasu H, Rochetti AL, Pires PR, Silva ER, Mesquita LG, Strefezzi RF, De Carvalho DD, Dagli ML. (2014) Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells. PLoS One 9:e99484.
- Gao J, Xie W. (2012) Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol Sci. 33: 552-58.
- Gao J, He J, Zhai Y, Wada T, Xie W. (2009) The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem. 284:25984-92.
- Goodwin B, Hodgson E, D’Costa DJ, Robertson GR, Liddle C. (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol. 62:359-65.
- Guo D, Sarkar J, Suino-Powell K, Xu Y, Matsumoto K, Jia Y, Yu S, Khare S, Haldar K, Rao MS, Foreman JE, Monga SP, Peters JM, Xu HE, Reddy JK. (2007) Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver. J Biol Chem. 282: 36766- 76.
- Hernandez JP, Mota LC, Baldwin WS. (2009) Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation. Curr Pharmacogenomics Pers Med. 7:81-105.
- Honkakoski P, Zelko I, Sueyoshi T, Negishi M. (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol. 18: 5652-58.
- Huang W, Zhang J, Moore DD. (2004) A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest. 113:137-43.
- Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, Moore DD. (2003) Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci USA. 100:4156-61.
- Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G, Moore DD. (2005) Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol. 19:1646-1653.
- Huang W, Zhang J, Wei P, Schrader WT, Moore DD. (2004) Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol Endocrinol. 18 : 2402-08.
- Ihunnah CA, Jiang M, Xie W. (2011) Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim Biophys Acta. 1812: 956-63.
- Innes KE, Wimsatt JH, McDuffie R. (2001) Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol. 97:905-10.
- Jyrkkarinne J, Windsh–gel B, Rünkkü T, Tervo AJ, K –blbeck J, Lahtela-Kakkonen M, Sipp W, Poso A, Honkakoski P. (2008) Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure activity relationship. J Med Chem. 51:7181-92.
- Kachaylo E, Yarushkin A, Pustylnyak V (2012) Constitutive androstane receptor activation by 2,4,6-triphenyldioxane1,3 suppresses the expression of the gluconeogenic genes. Eur J Pharmacol. 679:139-43.
- Kanno Y, Suzuki M, Nakahama T, Inouye Y. (2005) Characterization of nuclear localization signals and cytoplasmic retention region in the nuclear receptor CAR. Biochim Biophys Acta. 1745:215-22.
- Kanno Y, Tanuma N, Takahashi A, Inouye Y. (2013) TO901317, a potent LXR agonist, is an inverse agonist of CAR. J Toxicol Sci. 38:309-15.
- Kanno Y, Tanuma N, Yatsu T, Li W, Koike K, Inouye Y. (2014) Nigramide J is a novel potent inverse agonist of the human constitutive androstane receptor. Pharma Res Per. 2: e00018.
- Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA. (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor; farnesoid X-activated receptor; and constitutive androstane receptor. J Biol Chem. 277:2908-15.
- Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, Negishi M. (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol. 19: 6318-22.
- Kawana K, Ikuta T, Kobayashi Y, Gotoh O, Takeda K, Kawajiri K. (2003) Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol Pharmacol. 63:524-31.
- Kublbeck J, Jyrkkörinne J, Poso A, Turpeinen M, Sippl W, Honkakoski P, Windsh–gel B. (2008) Discovery of substituted sulfonamides and thiazolidin-4-one derivatives as agonists of human constitutive androstane receptor. Biochem Pharmacol. 76:1288 - 97.
- Kublbeck J, Laitinen T, Jyrkk örinne J, Rousu T, Tolonen A, Abel T, Kortelainen T, Uusitalo J, Korjamo T, Honkakoski P, Molnar F. (2011a) Use of comprehensive screening methods to detect selective human CAR activators. Biochem Pharmacol. 82:1994 - 2007.
- Kublbeck J, Jyrkkarinne J, Molnar F, Kuningas T, Patel J, Windshugel B, Nevalainen T, Laitinen T, Sippl W, Poso A, Honkakoski P. (2011b) New in vitro tools to study human constitutive androstane receptor (CAR) biology: discovery and comparison of human CAR inverse agonists. Mol Pharm. 8: 2424-33.
- Kumar S, Saradhi M, Chaturvedi NK, Tyagi RK. (2006) Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview. Mol Cell Endocrinol. 26:147-56.
- Ledda-Columbano GM, Pibiri M, Loi R, Perra A, Shinozuka H, Columbano A. (2000) Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4bis[2-(3,5-dichloropyridyloxy)]benzene. Am J Pathol. 156: 91-97.
- Lempiainen H, Molnar F, Gonzalez MM, Perakyla M, Carlberg C. (2005) Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein. Mol Endocrinol. 19: 2258-72.
- Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M, Wang H. (2008) The peripheral benzodiazepine receptor ligand 1(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol. 74: 443-53.
- Lim YP, Cheng CH, Chen WC, Chang SY, Hung DZ, Chen JJ, Wan L, Ma WC, Lin YH, Chen CY, Yokoi T, Nakajima M, Chen CJ. (2015) Allyl isothiocyanate (AITC) inhibits pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation and protects against acetaminophen and amiodarone induced cytotoxicity. Arch Toxicol. 89:57-72.
- Lynch C, Pan Y, Li L, Ferguson SS, Xia M, Swaan PW, Wang H. (2012) Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches. Pharm Res. 30:489-501.
- Maglich JM, Lobe DC, Moore JT. (2009) The nuclear receptor CAR(NR1I3) regulates serum triglyceride levels under conditions of metabolic stress. J Lipid Res. 50: 439-45.
- Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT. (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem. 278:17277-83.
- Maglich JM, Watson J, McMillen PJ, Goodwin B, Willson TM, Moore JT. (2004) The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem. 279: 19832-38.
- Mökinen J, Reinisalo M, Niemi K, Viitala P, Jyrkkarinne J, Chung H, Pelkonen O, Honkakoski P. (2003) Dual action of oestrogens on the mouse constitutive androstane receptor. Biochem J. 376: 465-72.
- Makinen J, Frank C, Jyrkkarinne J, Gynther J, Carlberg C, Honkakoski P. (2002) Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol. 62:366-78.
- Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-39.
- Masson D, Qatanani M, Sberna AL, Xiao R, Barros JPP de, Grober J, Deckert V, Athias A, Gambert P, Lagrost L, Moore DD, Assem M. (2008) Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice. J Lipid Res. 49: 1682-91.
- Masuyama H, Hiramatsu Y. (2012a) Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in high-fat diet-induced obese pregnant mice. Mol Cell Endocrinol. 348:120-27.
- Masuyama H, Hiramatsu Y. (2012b) Treatment with constitutive androstane receptor ligand during pregnancy prevents insulin resistance in offspring from high-fat diet-induced obese pregnant mice. Am J Physiol Endocrinol Metab. 303:E293-E300
- Miao J, Fang S, Bae Y, Kemper JK. (2006) Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J Biol Chem. 281:14537-46.
- Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA. (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem. 275: 15122-27.
- Mutoh S, Sobhany M, Moore R, Perera L, Pedersen L, Sueyoshi T, Negishi M. (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal. 6: ra31.
- Nuclear Receptors Nomenclature Committee (1999) A Unified Nomenclature System for the Nuclear Receptor Superfamily. Cell 97:161 - 63.
- Osabe M, Sugatani J, Fukuyama T, Ikushiro S, Ikari A, Miwa M. (2008) Expression of hepatic UDPglucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet. Drug Metab Dispos. 36: 294-302.
- Phillips JM, Yamamoto Y, Negishi M, Maronpot RR, Goodman JI. (2007) Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis. Toxicol Sci. 96:72-82.
- Pondugula SR, Dong H, Chen T. (2009) Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression. Expert Opin Drug Metab Toxicol. 5: 861-73.
- Rencurel F, Stenhouse A, Hawley SA, Friedberg T, Hardie DG, Sutherland C, Wolf CR. (2005) AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line. J Biol Chem. 280: 4367-73.
- Roth A, Looser R, Kaufmann M, Blattler SM, Rencurel F, Huang W, Moore DD, Meyer UA. (2008) Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol Pharmacol. 73:1282-89.
- Saradhi M, Kumar N, Reddy RC, Tyagi RK. (2006) Pregnane and Xenobiotic Receptor (PXR): A promiscuous xenosensor in human health and disease. J Endocrinol Reprod. 10: 1 - 12.
- Saradhi M, Sengupta A, Mukhopadhyay G, Tyagi RK. (2005) Pregnane and Xenobiotic Receptor (PXR/SXR) resides predominantly in the nuclear compartment of the interphase cell and associates with the condensed chromosomes during mitosis. Biochim Biophys Acta 15:85-94.
- Savkur RS, Wu Y, Bramlett KS, Wang M, Yao S, Perkins D, Totten M, Searfoss G 3rd, Ryan TP, Su EW, Burris TP. (2003) Alternative splicing within the ligand binding domain of the human constitutive androstane receptor. Mol Genet Metab. 80: 216-26.
- Sberna AL, Assem M, Gautier T, Grober J, Guiu B, Jeannin A, Pais de Barros JP, Athias A, Lagrost L, Masson D. (2011a) Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice. J Hepatol. 55: 154-61.
- Sberna AL, Assem M, Xiao R, Ayers S, Gautier T, Guiu B, Deckert V, Chevriaux A, Grober J, Le Guern N, Pais de Barros JP, Moore DD, Lagrost L, Masson D. (2011b) Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 31:2232-39.
- Seely EW, Solomon CG. (2003) Insulin resistance and its role in pregnancy induced hypertension. J Clin Endocrinol Metab. 88:2393-98.
- Shank LC, Paschal BM. (2005) Nuclear transport of steroid hormone receptors. Crit Rev Eukaryot Gene Expr. 15: 49-73.
- Squires EJ, Sueyoshi T, Negishi M. (2004) Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem. 279: 49307-14.
- Stedman CA, Liddle C, Coulter SA, Sonoda J, Alvarez JG, Moore DD, Evans RM, Downes M. (2005) Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci USA. 102: 2063-68.
- Sueyoshi T, Negishi M. (2001) Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol. 41: 123-43.
- Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH, Ida S, Owens IS, Negishi M, Sueyoshet T. (2001) The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33:1232-38.
- Swales K, Negishi M. (2004) CAR, driving into the future. Mol Endocrinol. 18:1589-98.
- Takizawa D, Kakizaki S, Horiguchi N, Yamazaki Y, Tojima H, Mori M. (2011) Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis. Carcinogenesis 32:576-83.
- Thigpen KG. (2004) International sequencing consortium. Environ Health Perspect. 112: A406.
- Timsit YE, Negishi M. (2007) CAR and PXR: the xenobiotic-sensing receptors. Steroids 72: 231-46.
- Tolson AH, Wang H. (2010) Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev. 62: 1238-49.
- Tzameli I, Pissios P, Schuetz EG, Moore DD. (2000) The xenobiotic compound 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol. 20: 2951-58.
- Wagner M, Halilbasic E, Marschall H-U, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M. (2005) CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.Hepatology 42: 420-30.
- Wallin A, Boräus LO. (1984) Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants. A controlled study of bilirubin disappearance and infant behavior. Acta Paediatr Scand. 73:488-97.
- Wang H, Faucette S, Moore R, Sueyoshi T, Negishi M, LeCluyse E. (2004) Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem. 279:29295-301.
- Wienekea N, Hirsch-Ernstb KI, Kunaa M, Kerstenc S, Puschela GP. (2007) PPAR[alpha]-dependent induction of the energy homeostasis-regulating nuclear receptor NR1i3 (CAR) in rat hepatocytes: potential role in starvation adaptation. FEBS Lett. 581: 5617-26.
- Yaffe SJ, Levy G, Matsuzawa T, Baliah T. (1966) Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med. 275:1461-66.
- Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR. (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64:7197- 200.
- Yamazaki Y, Kakizaki S, Horiguchi N, Sohara N, Sato K, Takagi H, Mori M, Negishi M. (2007) The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis. Gut 56: 565-74.
- Yao R, Yasuoka A, Kamei A, Kitagawa Y, Rogi T, Taieishi N, Tsuruoka N, Kiso Y, Misaka T, Abe K. (2011) Polyphenols in alcoholic beverages activating constitutive androstane receptor CAR. Biosci Biotechnol Biochem. 75:1635-37.
- Yoshinari K, Kobayashi K, Moore R, Kawamoto T, Negishi M. (2003) Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett. 548: 17-20.
- Yoshinari K, Sueyoshi T, Moore R, Negishi M. (2001) Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYB2B1 gene by phenobarbital in rat livers. Mol Pharmacol. 59: 278-84.
- Yoshinari K, Yoda N, Toriyabe T, Yamazoe Y. (2010) Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5’-flanking region. Biochem Pharmacol. 79:261-69.
- Zelko I, Sueyoshi, T, Kawamoto, T, Moore R, Negishi M. (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol. 21: 2838-46.
- Zhai Y, Wada T, Zhang B, Khadem S, Ren S, Kuruba R, Li S et al. (2010) A functional crosstalk between liver X receptor - α and Constitutive androstane receptor AR links lipogenesis and xenobiotic responses. Mol Pharmacol. 78 : 666-74.
- Clinical Correlates in Drug-Herbal Interactions Mediated via Nuclear Receptor PXR Activation and Cytochrome P450 Induction
Abstract Views :238 |
PDF Views:0
Authors
Affiliations
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi – 110067, IN
2 Department of Animal Science, School of Life Sciences, Bharathidasan University Tiruchirappalli - 620 024, IN
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi – 110067, IN
2 Department of Animal Science, School of Life Sciences, Bharathidasan University Tiruchirappalli - 620 024, IN
Source
Journal of Endocrinology and Reproduction, Vol 12, No 1 (2008), Pagination: 1-12Abstract
Pregnane and Xenobiotic Receptor (PXR), a vital xenosensor, acts as master regulator of phase-I (cytochrome P450) and phase-II enzymes (glutathione S-transferases, sulfotransferases, and uridine 5'-diphosphate glucuronosyltransferases) as well as several drug transporters (multi-drug resistance protein, and multidrug resistance-associated protein). PXR can bind to a variety of chemically distinct endobiotics (steroids, bile acids and their derivatives, vitamins, etc.) and xenobiotics (prescription drugs, herbal medicines, endocrine disruptors, etc.). Activation of PXR by various compounds leads to trans-activation of PXR-target genes involved in detoxification system (phase-I and phase-II enzymes, and efflux proteins). Herbal medicines are readily used without prescription under the belief that anything natural is safe. These medicines contain active chemical constituents which execute distinctly different or similar pharmacological response(s). But, like prescription drugs, herbal drugs also have both therapeutic and, sometimes, adverse effects. Some of the herbal drugs induce drug metabolizing enzymes (especially CYP3A4) and drug efflux proteins via activation of PXR. Phase-I enzyme CYP3A4 is involved in the metabolism of 50-60% of clinical drugs as well as the chemical ingredients in herbal medicines. In addition to this, 25-30% of these compounds are metabolized by the CYP2B isoenzymes. The combined metabolic effects of phase-I and phase-II enzymes and drug transporters, following induction by therapeutic molecules, constitute the molecular basis for many drug-herbal interactions. For example, if one drug activates PXR, it can encourage the elimination of a co-administered drug that is also metabolized and eliminated by PXR-target gene products, thereby affecting the therapeutic efficacy of the drug in the context of combination therapy. The present review highlights some of the recent clinical correlates in drug-herbal interactions mediated primarily via PXR and cytochrome P450.Keywords
Drug-Herbal Interactions, Pregnane and Xenobiotic Receptor (PXR), Cytochrome P450 (CYP450), Drug Transporters.- Networking Strategies and Emerging Roles of Pregnane & xenobiotic Receptor (PXR) in Normal and Pathological States
Abstract Views :260 |
PDF Views:0
Authors
Affiliations
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi – 110067, IN
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi – 110067, IN
Source
Journal of Endocrinology and Reproduction, Vol 14, No 1 (2010), Pagination: 1-8Abstract
The Pregnane & Xenobiotic Receptor (PXR), a member of the nuclear receptor family of ligand-activated transcription factors, is an integral component of the body's defense mechanism against toxic xenobiotics and endobiotic metabolites. Due to highly promiscuous nature and broad ligand specificity, this 'xenosensor' has emerged as a master-regulator of xenobiotic metabolism and regulator of all phases of drug metabolism and clearance. It has also been implicated to play an important role in induction of drug-drug interactions. During the past few years, research has unveiled some novel and mostly unanticipated roles for PXR in inflammation, lipid homeostasis, bone homeostasis, vitamin D metabolism, energy homeostasis, endocrine-related functions and cancer. Recent evidences have revealed existence of PXR cross-talk with several other cellular signaling pathways that profoundly expand the horizon of this promiscuous xenosensor. These cross-talks between PXR and other signaling pathways may elucidate molecular mechanisms to explain the involvement of PXR in several hitherto unanticipated physiological functions. The present article summarizes some of the important cross-talks of PXR with other nuclear receptors and different signaling pathways to describe how these cross-talks integrate into novel biological functions. It is anticipated that better understanding towards the mechanisms of PXR cross-talk might divulge novel therapeutic approaches to combat various diseases.Keywords
Cross-Talk, Drug Metabolism, Nuclear Receptor, PXR, Xenobiotics.- A Compendium of Nuclear Receptors:The Superfamily of Ligand-Modulated Transcription Factors
Abstract Views :358 |
PDF Views:0
Authors
Affiliations
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi – 110067, IN
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi – 110067, IN
Source
Journal of Endocrinology and Reproduction, Vol 20, No 1 (2016), Pagination: 1-27Abstract
The ‘Nuclear Receptor Super-family’ is a group of ligand-modulated transcription factors with 48 members identified in human genome. Members of this family of receptors are now established to be involved in regulation of a plethora of physiological processes in the paradigms of development, reproduction, metabolism and homeostasis. Also, in the myriads of patho-physiological processes, these receptors have consistently exhibited enormous potential as targets for the treatment of diseases such as cancers, osteoporosis, diabetes, obesity, coronary heart disease, asthma, hypertension, thyroid conditions and multiple other metabolic disorders. In recent times, it is estimated that about 15% of the clinical drugs, used in treatments of different ailments, target nuclear receptors. These receptors include steroid/thyroid hormone receptors and orphan/adopted receptors that function as intra-cellular transcription factors to regulate expression of several hundreds of genes in response to their cognate ligands. Interestingly, nuclear receptors are also being assigned a novel role in serving as ‘epigenetic marks’ for the retention and transmission of cellular ‘transcriptional memory’. These receptors function primarily either as homodimers or heterodimers with Retinoid X Receptor (RXR) or sometimes as monomers. Being ‘drug responsive’ these receptors offer attractive targets for drug discovery since their activities can be favorably modulated by interacting ligands. However, many of the newly discovered members of this family of receptors remain incompletely understood, both in terms of physiological roles and activating ligands. In brief, nuclear receptors represent enormous potential for drug discovery and are continuously being examined to unravel the mysteries underlying their mechanisms of action. It has been well-over three decades since the cloning of steroid/nuclear receptors in the 1980s. Therefore, it’s only appropriate to prepare a comprehensive review that provides a compendium of facts and events from receptor cloning and characterization to establishment of receptor domain structures, physiological functioning and consequences of receptor malfunctioning. This review is expected to serve as a refreshing compendium of nuclear receptors for both, the beginners, as well as experts working in the areas of nuclear receptor biology.Keywords
Classification, Diseases, Diversity, Drug Targets, Epigenetics, Nuclear Receptors, Transcription Factors, Structure.References
- Adams MD, Celniker SE, Holt RA et al. (196 co-authors).The genome sequence of Drosophila melanogaster. Science.2000; 287:2185–95. PMid:10731132. Available from: https://doi.org/10.1126/science.287.5461.2185
- Agoulnik IY, Cho Y, Niederberger C, Kieback DG, Cooney AJ. Cloning, expression analysis and chromosomal localization of the human nuclear receptor gene GCNF. FEBS Lett. 1998; 424(1-2):73–8. Available from: https://doi.org/10.1016/S0014-5793(98)00142-2
- Alberti S, Steffensen KR, Gustafsson JA. Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta. Gene. 2000; 243(1-2):93–103. Available from: https://doi.org/10.1016/S0378-1119(99)00555-7
- Alexander SP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA.The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. British Journal of Pharmacology.2015; 172:5956–78. PMid:26650443 PMCid:PMC4718213.Available from: https://doi.org/10.1111/bph.13353
- Almasan A, Mangelsdorf DJ, Ong ES, Wahl GM, Evans RM. Chromosomal localization of the human retinoid X receptors. Genomics. 1994; 20(3):397–403. PMid:8034312.Available from: https://doi.org/10.1006/geno.1994.1193
- André E, Conquet F, Steinmayr M, Stratton SC, Porciatti V, Becker-André M. Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice.EMBO J. 1998; 17(14):3867–77. PMid:9670004 PMCid:PMC1170722.Available from: https://doi.org/10.1093/emboj/ 17.14.3867
- Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G, Pfahl M. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol. 1995; 14(10):7025–35. Available from: https://doi.org/10.1128/MCB.14.10.7025
- Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science.1987; 237(4812):268–75. Available from: https://doi.org/10.1126/science.3037703
- Arthur Zelent, Andrée Krust, Martin Petkovich, Philippe Kastner and Pierre Chambon Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin. Nature. 1989; 339:714–7. PMid:2544807.Available from: https://doi.org/10.1038/339714a0
- Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol. 1994; 14(3):1544– 52. PMid:8114692 PMCid:PMC358513. Available from: https://doi.org/10.1128/MCB.14.3.1544
- Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O’Malley BW.Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl Acad Sci USA. 1988; 85:3294–8. PMid:2835767 PMCid:PMC280195. Available from: https://doi.org/10.1073/pnas.85.10.3294
- Becker-André M, André E, DeLamarter JF. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun. 1993; 194(3):1371–9. PMid:7916608. Available from: https://doi.org/10.1006/bbrc.1993.1976
- Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Bäckman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.Proc Natl Acad Sci U S A. 1998; 95(21):12208–13.PMid:9770465 PMCid:PMC22810. Available from: https:// doi.org/10.1073/pnas.95.21.12208
- Black BE, Holaska, JM, Rastinejad F and Paschal BM. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Current Biology. 2001; 11:1749– 58. Available from: https://doi.org/10.1016/S09609822(01)00537-1
- Blumberg B, Kang H, Bolado JJr, Chen H, Craig AG, Moreno TA, Umesono K, Perlmann T, De Robertis EM, Evans RM. BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites.Genes Dev. 1998; 12(9):1269–77. PMid:9573044 PMCid: PMC316771. Available from: https://doi.org/10.1101/ gad.12.9.1269
- Blumberg B, Sabbagh WJr, Juguilon H, Bolado JJr, van Meter CM, Ong ES, Evans RM.. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 1998a; 12(20):3195–205. PMid:9784494 PMCid:PMC317212.Available from: https://doi.org/10.1101/gad.12.20.3195
- Bonnelye E, Vanacker JM, Desbiens X, Begue A, Stehelin D, Laudet V. Rev-erb beta, a new member of the nuclear receptor superfamily, is expressed in the nervous system during chicken development. Cell Growth Differ. 1994; 5(12):1357–65. PMid:7696184.
- Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science. 1990; 249(4976):1577– 80. PMid:2218500. Available from: https://doi.org/10.1126/ science.2218500
- Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature. 1995; 375(6530):377–82. PMid:7760929. Available from: https:// doi.org/10.1038/375377a0
- Brand N, Petkovich M, Krust A, Chambon P, de Thé H, Marchio A, Tiollais P, Dejean A. Identification of a second human retinoic acid receptor. Nature. 1988; 332:850–3. PMid:2833708. Available from: https://doi.org/10.1038/332850a0
- Bridgham JT, Eick GN, Larroux C, Deshpande K, Harms MJ, Gauthier ME, Ortlund EA, Degnan BM, Thornton JW.Protein evolution by molecular tinkering: diversification of the nuclear receptor superfamily from a ligand-dependent ancestor. PLoS Biol. 2010; 8(10):e1000497. PMid:20957188 PMCid:PMC2950128. Available from: https://doi.org/10.1371/journal.pbio.1000497
- Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HF. Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet.1989; 44(2):264–9. PMid:2563196 PMCid:PMC1715398.
- Bunce CM, Campbell MJ. Nuclear Receptors, Current Concepts and Future Challenges. Bunce CM, Campbell MJ, editors.Nuclear Receptors an Introductory Overview. 2010.p. 1–13
- Burmester JK, Maeda N, DeLuca HF. Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. Proc Natl Acad Sci U S A. 1988; 85(4):1005–9. PMid:2829212 PMCid:PMC279689. Available from: https://doi.org/10.1073/pnas.85.4.1005
- Carlberg C, van Huijsduijnen RH, Staple JK, DeLamarter JF, Becker-André M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol. 1994; 8(6):757–70.PMid:7935491. Available from: https://doi.org/10.1210/ me.8.6.757
- Castillo SO, Xiao Q, Lyu MS, Kozak CA, Nikodem VM. Organization, sequence, chromosomal localization, and promoter identification of the mouse orphan nuclear receptor Nurr1 gene. Genomics. 1997; 41(2):250–7. PMid:9143501.Available from: https://doi.org/10.1006/geno.1997.4677
- Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996; 10(9):940–54. PMid:8801176.
- Chang C, Da Silva SL, Ideta R, Lee Y, Yeh S, Burbach JP.Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily. Proc Natl Acad Sci USA.1994; 91(13):6040–4. PMid:8016112 PMCid:PMC44133.Available from: https://doi.org/10.1073/pnas.91.13.6040
- Chang C, Kokontis J, Liao SS, Chang Y. Isolation and characterization of human TR3 receptor: a member of steroid receptor superfamily. J Steroid Biochem.1989; 34(1-6):391–5. Available from: https://doi.org/10.1016/0022-4731(89)90114-3
- Chang C, Kokontis J. Identification of a new member of the steroid receptor super-family by cloning and sequence analysis. Biochem. Biophys. Res. Commun.1988; 155 (2): 971–7. Available from: https://doi.org/10.1016/S0006291X(88)80591-6
- Chartier FL, Bossu JP, Laudet V, Fruchart JC, Laine B. Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene. 1994; 147(2):269–72. Available from: https://doi.org/10.1016/0378-1119(94)90079-5
- Chen F, Figueroa DJ, Marmorstein AD, Zhang Q, Petrukhin K, Caskey CT, Austin CP. Retina-specific nuclear receptor: A potential regulator of cellular retinaldehyde-binding protein expressed in retinal pigment epithelium and Müller glial cells. Proc Natl Acad Sci U S A. 1999; 96(26):15149– 54. PMid:10611353 PMCid:PMC24788. Available from: https://doi.org/10.1073/pnas.96.26.15149
- Chen F, Zhang Q, McDonald T, Davidoff MJ, Bailey W, Bai C, Liu Q, Caskey CT. Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR Gene. 1999a; 228(1-2):101–9. Available from: https:// doi.org/10.1016/S0378-1119(98)00619-2
- Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, Moore DD. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem.1997; 272(38):23565–71. PMid:9295294. Available from: https://doi.org/10.1074/jbc.272.38.23565
- Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J, Cooper CS. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.Oncogene. 1996; 12(2):229–35. PMid:8570200.
- Dash AK, Yende AS, Kumar S, Singh SK, Kotiya D, Rana M, Tyagi RK. The Constitutive Androstane Receptor (CAR): a nuclear receptor in health and disease. J Endocrinol Reprod.2014; 18(2):59–74.
- Dayton AI, Selden JR, Laws G, Dorney DJ, Finan J, Tripputi P, Emanuel BS, Rovera G, Nowell PC, Croce CM. A human c-erbA oncogene homologue is closely proximal to the chromosome 17 break point in acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1984; 81(14):4495–9.PMid:9295294. Available from: https://doi.org/10.1073/ pnas.81.14.4495PMid:6589608 PMCid:PMC345617
- de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature. 1990; 347(6293):558–61. PMid:2170850.Available from: https://doi.org/10.1038/347558a0
- Drabkin H, Kao FT, Hartz J, Hart I, Gazdar A, Weinberger C, Evans R, Gerber M. Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci U S A.1988; 85(23):9258–62. PMid:2848257 PMCid:PMC282718.Available from: https://doi.org/10.1073/pnas.85.23.9258
- Drewes T, Senkel S, Holewa B, Ryffel GU. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol. 1996; 16(3):925–31. PMid:8622695 PMCid:PMC231074. Available from: https://doi.org/10.1128/MCB.16.3.925
- Dumas B, Harding HP, Choi HS, Lehmann KA, Chung M, Lazar MA, Moore DD. A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb Mol Endocrinol. 1994; 8:996–1005. PMid:7997240. Available from: https://doi.org/10.1210/mend.8.8.7997240
- Enmark E, Kainu T, Pelto-Huikko M, Gustafsson JA. Identification of a novel member of the nuclear receptor superfamily which is closely related to Rev-ErbA. Biochem Biophys Res Commun. 1994; 204(1):49–56. PMid:7945391.Available from: https://doi.org/10.1006/bbrc.1994.2424
- Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson JA. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab.1997; 82(12):4258–65. PMid:9398750. Available from: https://doi.org/10.1210/jcem.82.12.4470
- Eudy JD, Yao S, Weston MD, Ma-Edmonds M, Talmadge CB, Cheng JJ, Kimberling WJ, Sumegi J. Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics. 1998; 50(3):382–4. PMid:9676434.Available from: https://doi.org/10.1006/geno.1998.5345
- Evans RM, Mangelsdorf DJ. Nuclear Receptors, RXR, and the Big Bang. Cell. 2014; 157(1):255–66. PMid:24679540 PMCid:PMC4029515. Available from: https://doi.org/10.1016/j.cell.2014.03.012
- Evans RM. Journal of Molecular Endocrinology 25th anniversary special issue. J Mol Endocrinol. 2013; 51:E1–E3.PMid:24280960. Available from: https://doi.org/10.1530/ JME-13-0257
- Fan YS, Eddy RL, Byers MG, Haley LL, Henry WM, Nowak NJ, Shows TB. 1989. The human mineralocorticoid receptor gene (MLR) is located on chromosome 4 at q31.2.Cytogenet Cell Genet. 1989; 52(1-2):83–4. PMid:2558856.Available from: https://doi.org/10.1159/000132846
- Forman BM, Chen J, Blumberg B, Kliewer SA, Henshaw R, Ong ES and Evans RM. Cross-Talk among RORal and the Rev-erb Family of Orphan Nuclear Receptors. Mol. Endocrinol.1994; 8:1253–61. PMid:7838158. Available from: https://doi.org/10.1210/mend.8.9.7838158
- Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C. Identification of a nuclear receptor that is activated by farnesol metabolites.Cell. 1995; 81(5):687–93. Available from: https://doi.org/10.1016/0092-8674(95)90530-8
- Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol. 2003; 65:261–311. PMid:12518001. Available from: https://doi.org/10.1146/annurev.physiol.65.092101.142528
- Francke U, Foellmer BE. The glucocorticoid receptor gene is in 5q31-q32 [corrected]. Genomics. 1989; 4(4):610612. Available from: https://doi.org/10.1016/08887543(89)90287-5
- Galarneau L, Drouin R, Bélanger L. Assignment of the fetoprotein transcription factor gene (FTF) to human chromosome band 1q32.11 by in situ hybridization. Cytogenet Cell Genet. 1998; 82(3-4):269–70. PMid:9858833.: https:// doi.org/10.1159/000015116
- Germain P, Staels B, Dacquet C, Spedding M, Laudet V.Overview of nomenclature of nuclear receptors. Pharmacol.Rev. PMid:17132848. 2006; 58(4):685–704. Available from: https://doi.org/10.1124/pr.58.4.2
- Giguere V, S. Ong E, Segui P, Evans RM. Identification of a receptor for the morphogen retinoic acid. Nature. 1987; 330:624–9. PMid:2825036. Available from: https://doi.org/10.1038/330624a0
- Giguère V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 1994; 8(5):538–53. PMid:7926749. Available from: https://doi.org/10.1101/gad.8.5.538
- Giguère V, Yang N, Segui P, Evans RM. Identification of a new class of steroid hormone receptors. Nature. 1988; 331(6151):91–4. PMid:3267207. Available from: https:// doi.org/10.1038/331091a0
- Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. Human oestrogen receptor cDNA:sequence, expression and homology to v-erb-A. Nature.1986; 320(6058):134–9. Available from: https://doi.org/10.1038/320134a0
- Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science. 1986; 231(4742):1150–4.PMid:3753802. Available from: https://doi.org/10.1126/science.3753802
- Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Greene G, Nimer SD. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 1995; 4(4-5):281–99.PMid:7787419.
- Gronemeyer H, Laudet V. Transcription factors 3: nuclear receptors. Protein Profile. 1995; 2(11):1173–308.PMid:8681033.
- Guiochon-Mantel A, Delabre K, Lescop P, Milgrom E. Nuclear localization signals also mediate the outward movement of proteins from the nucleus. Proc Natl Acad Sci U S A.1994; 91(15):7179–83. PMid:8041765 PMCid:PMC44362.Available from: https://doi.org/10.1073/pnas.91.15.7179
- Haider NB, Jacobson SG, Cideciyan AV, Swiderski R, Streb LM, Searby C, Beck G, Hockey R, Hanna DB, Gorman S, Duhl D, Carmi R, Bennett J, Weleber RG, Fishman GA, Wright AF, Stone EM, Sheffield VC. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat Genet. 2000; 24(2):127–31. PMid:10655056. Available from: https://doi.org/10.1038/72777
- Hamada K, Gleason SL, Levi BZ, Hirschfeld S, Appella E, Ozato K. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc Natl Acad Sci U S A.1989; 86(21):8289–93. PMid:2554307 PMCid:PMC298266.Available from: https://doi.org/10.1073/pnas.86.21.8289
- Hamilton BA, Frankel WN, Kerrebrock AW, Hawkins TL, FitzHugh W, Kusumi K, Russell LB, Mueller KL, van Berkel V, Birren BW, Kruglyak L, Lander ES. Disruption of the nuclear hormone receptor RORalpha in staggerer mice.Nature. 1996; 379(6567):736–9. PMid:8602221. Available from: https://doi.org/10.1038/379736a0
- Hanna RN, Leo MC, Harper GH, Dominika N, Angela MG, Jennifer AP, Frederic G, Catherine CH. The Transcription Factor NR4A1 (Nur77) Controls Bone Marrow Differentiation and the Survival of Ly6C- Monocytes. Nature Immunology. 2011; 12(8):778–85. PMid:21725321 PMCid: PMC3324395. Available from: https://doi.org/10.1038/ ni.2063
- Hedvat CV, Irving SG. The isolation and characterization of MINOR, a novel mitogen-inducible nuclear orphan receptor.Mol Endocrinol. 1995; 9(12):1692–700. Available from: https://doi.org/10.1210/mend.9.12.8614405
- Hirose T, Fujimoto W, Tamaai T, Kim KH, Matsuura H, Jetten AM. TAK1: Molecular cloning and characterization of a new member of the nuclear receptor superfamily. Mol Endocrinol. 1994; 8(12):1667–80. PMid:7708055. Available from: https://doi.org/10.1210/mend.8.12.7708055
- Hirose T, Smith RJ, Jetten AM. ROR gamma: The third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun. 1994a; 205(3):1976–83. Available from: https:// doi.org/10.1006/bbrc.1994.2902PMid:7811290
- Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985; 318(6047):635–41. PMid:2867473. Available from: https:// doi.org/10.1038/318635a0
- Hong H, Yang L, Stallcup MR. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem. 1999; 274(32):22618–26. PMid:10428842. Available from: https://doi.org/10.1074/jbc.274.32.22618
- Ishikawa T, Umesono K, Mangelsdorf DJ, Aburatani H, Stanger BZ, Shibasaki Y, Imawari M, Evans RM, Takaku F.A functional retinoic acid receptor encoded by the gene on human chromosome 12. Mol Endocrinol. 1990; 4(6):837– 44. PMid:2172793. Available from: https://doi.org/10.1210/ mend-4-6-837
- Jackson A, Panayiotidis P, Foroni L. The human homologue of the Drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21. Genomics. 1998;50(1):34–43. PMid:9628820. Available from: https://doi.org/10.1006/geno.1998.5270
- Jones KA, Fitzgibbon J, Woodward KJ, Goudie D, FergusonSmith MA, Povey S, Wolfe J, Solomon E. Localization of the retinoid X receptor alpha gene (RXRA) to chromosome 9q34. Ann Hum Genet. 1993; 57(Pt 3):195–201. PMid:8257089. Available from: https://doi.org/10.1111/j.1469-1809.1993.tb01595.x
- Kanno, Y, Inouye Y. Molecular basis of the intracellular localization of the Constitutive Androstane Receptor (CAR).Journal of Health Science. 2008; 54(3):261–6. Available from: https://doi.org/10.1248/jhs.54.261
- Khan SA, Vanden Heuvel JP. Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review).J Nutr Biochem. 2003; 14:554–67. Available from: https://doi.org/10.1016/S0955-2863(03)00098-6
- Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A.1994; 91(15):7355–9. PMid:8041794 PMCid:PMC44398.Available from: https://doi.org/10.1073/pnas.91.15.7355
- Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterström RH, Perlmann T, Lehmann JM. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 1998; 92(1):73–82. Available from: https:// doi.org/10.1016/S0092-8674(00)80900-9
- Kobayashi M, Takezawa S, Hara K, Yu RT, Umesono Y, Agata K, Taniwaki M, Yasuda K, Umesono K. Identification of a photoreceptor cell-specific nuclear receptor. Proc Natl Acad Sci U S A. 1999; 96(9):4814–9. PMid:10220376 PMCid: PMC21774. Available from: https://doi.org/10.1073/ pnas.96.9.4814
- Koh YS, Moore DD. Linkage of the nuclear hormone receptor genes NR1D2, THRB, and RARB: evidence for an ancient, large-scale duplication. Genomics. 1999; 57(2):289–92. PMid:10198169. Available from: https://doi.org/10.1006/geno.1998.5683
- Krust A, Green S, Argos P, Kumar V, Walter P, Bornert JM, Chambon P. The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J. 1986; 5(5):891–7. PMid:3755102 PMCid:PMC1166879.
- Krust A, Kastner P, Petkovich M, Zelent A, Chambon P. A third human retinoic acid receptor, hRAR-gamma. Proc Natl Acad Sci U S A. 1989; 86(14):5310–4. PMid:2546152 PMCid:PMC297611. Available from: https://doi.org/10.1073/pnas.86.14.5310
- Kumar S, Saradhi M, Chaturvedi NK, Tyagi RK. Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview. Mol Cell Endocrinol. 2006; 246(12):147–56. PMid:16388893. Available from: https://doi.org/10.1016/j.mce.2005.11.028
- Kumar S, Saradhi M, Chaturvedi NK, Tyagi RK. Retention and transmission of active transcription memory from progenitor to progeny cells via ligand-modulated transcription factors: elucidation of a concept by BIOPIT model. Cell Biol Int. 2012; 36(2):177–82. PMid:22007870. Available from: https://doi.org/10.1042/CBI20090329
- Labelle Y, Bussières J, Courjal F, Goldring MB. The EWS/ TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene. 1999; 18(21):3303–8.PMid:10359536. https://doi.org/10.1038/sj.onc.1202675
- Labelle Y, Zucman J, Stenman G, Kindblom LG, Knight J, Turc-Carel C, Dockhorn-Dworniczak B, Mandahl N, Desmaze C, Peter M, et al. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet. 1995; 4(12):2219–26. PMid:8634690. Available from: https://doi.org/10.1093/hmg/4.12.2219
- Ladias JA, Karathanasis SK. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science. 1991; 251(4993):561–5.PMid:1899293. Available from: https://doi.org/10.1126/science.1899293
- Laudet V, Gronemeyer H. The Nuclear Receptors FactsBook. London, UK: Academic Press; 2002.
- Law ML, Kao FT, Wei Q, Hartz JA, Greene GL, ZaruckiSchulz T, Conneely OM, Jones C, Puck TT, O’Malley BW, et al. The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2. Proc Natl Acad Sci U S A. 1987; 84(9):2877– 81. PMid:3472240 PMCid:PMC304763. Available from: https://doi.org/10.1073/pnas.84.9.2877
- Law SW, Conneely OM, O’Malley BW. Molecular cloning of a novel member of the nuclear receptor superfamily related to the orphan receptor, TR2. Gene Expr. 1994; 4(1-2):77– 84. PMid:7841789
- Lazar MA, Hodin RA, Darling DS, Chin WW. A Novel Member of the Thyroid/Steroid Hormone Receptor Family Is Encoded by the Opposite Strand of the Rat c-erbAot Transcriptional Unit. Mol. Cell. Biol. 1989; 9(3):1128–36.PMid:2542765 PMCid:PMC362703. Available from:https://doi.org/10.1128/MCB.9.3.1128
- Le Beau MM, Song C, Davis EM, Hiipakka RA, Kokontis JM, Liao S. Assignment of the human ubiquitous receptor gene (UNR) to 19q13.3 using fluorescence in situ hybridization.Genomics. 1995; 26(1):166–8. Available from: https://doi.org/10.1016/0888-7543(95)80100-Z
- le Maire A, Bourguet W, Balaguer P. A structural view of nuclear hormone receptor: endocrine disruptor interactions.Cell Mol Life Sci. 2010; 67(8):1219–37. PMid:20063036.Available from: https://doi.org/10.1007/s00018-009-0249-2
- Lee HK, Lee YK, Park SH, Kim YS, Park SH, Lee JW, Kwon HB, Soh J, Moore DD, Choi HS. Structure and expression of the orphan nuclear receptor SHP gene. J Biol Chem. 1998; 273(23):14398–402. PMid:9603951. Available from: https:// doi.org/10.1074/jbc.273.23.14398
- Lee YF, Shyr CR, Thin TH, Lin WJ, Chang C. Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: a unique signaling pathway in the steroid receptor superfamily.Proc Natl Acad Sci U S A. 1999; 96(26):14724–9.PMid:10611280 PMCid:PMC24715. Available from:https://doi.org/10.1073/pnas.96.26.14724
- Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest.1998; 102(5):1016–23. PMid:9727070 PMCid:PMC508967.Available from: https://doi.org/10.1172/JCI3703
- Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 1992; 68(2):377–95. Available from: https://doi.org/10.1016/0092-8674(92)90478-U
- Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol.1988; 2(12):1265–75. PMid:3216866. Available from: https://doi.org/10.1210/mend-2-12-1265
- Mages HW, Rilke O, Bravo R, Senger G, Kroczek RA. NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3. Mol Endocrinol.1994: 8(11):1583–91. PMid:7877627. Available from: https://doi.org/10.1210/mend.8.11.7877627
- Maglich JM, a Sluder XG, Y Shi, D DM, Carrick K, Kamdar K, Willson TM, Moore JT. Comparison of complete nuclear receptor sets from the human, caenorhabditis elegans and drosophila genomes. Genome Biology. 2001; 2(8):RESEARCH0029.
- Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992; 6(3):329–44. PMid:1312497. https:// doi.org/10.1101/gad.6.3.329
- Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway.Nature. 1990; 345(6272):224–9. PMid:2159111. Available from: https://doi.org/10.1038/345224a0
- Mattei MG, Krust A, Stropp U, Mattei JF, Chambon P. As signment of the human progesterone receptor to the q22 band of chromosome 11. Hum Genet. 1988; 78(1):96–7.PMid:3338797. Available from: https://doi.org/10.1007/ BF00291245
- Mattei MG, Rivière M, Krust A, Ingvarsson S, Vennström B, Islam MQ, Levan G, Kautner P, Zelent A, Chambon P, et al. Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. Genomics.1991; 10(4):1061–9. Available from: https://doi.org/10.1016/0888-7543(91)90199-O
- McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O’Malley BW. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science. 1987; 235(4793):1214–7. PMid:3029866. Available from: https:// doi.org/10.1126/science.3029866
- Medvedev A, Chistokhina A, Hirose T, Jetten AM. Genomic structure and chromosomal mapping of the nuclear orphan receptor ROR gamma (RORC) gene. Genomics. 1997; 46(1):93–102. PMid:9403063. Available from: https://doi.org/10.1006/geno.1997.4980
- Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique.Genomics. 1993; 17(1):263–5. PMid:8406468. Available from:https://doi.org/10.1006/geno.1993.1320
- Misrahi M, Atger M, d’Auriol L, Loosfelt H, Meriel C, Fridlansky F, Guiochon-Mantel A, Galibert F, Milgrom E. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys ResCommun. 1987; 143(2):740–8. Available from: https://doi.org/10.1016/0006-291X(87)91416-1
- Mitelman F, Manolov G, Manolova Y, Billström R, Heim S, Kristoffersson U, Mandahl N, Ferro MT, San Roman C.High resolution chromosome analysis of constitutional and acquired t(15;17) maps c-erbA to subband 17q11.2. Cancer Genet Cytogenet. 1986; 22(2):95–8. Available from: https:// doi.org/10.1016/0165-4608(86)90168-8
- Miyajima N, Horiuchi R, Shibuya S, Matsubara K, Toyoshima K, Yamamoto T. Two erbA homologs encoding proteins with different T (3) binding capacities are transcribed from opposite DNA strands of the same genetic locus. Cell. 1989; 57:31–9. Available from: https://doi.org/10.1016/00928674(89)90169-4
- Miyajima N, Kadowaki Y, Fukushige S, Shimizu S, Semba K, Yamanashi Y, Matsubara K, Toyoshima K, and Yamamoto T. Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other. Nucleic Acids Res. 1988; 16:11057–74. PMid:2905047 PMCid:PMC338996. Available from: https://doi.org/10.1093/nar/16.23.11057
- Monaghan AP, Grau E, Bock D, Schütz G. The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain. Development. 1995; 121(3):839– 53. PMid:7720587.
- Montano MM, Müller V, Trobaugh A, Katzenellenbogen BS. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.Mol Endocrinol. 1995; 9(7):814–25.PMid:7476965.Available from: https://doi.org/10.1210/me.9.7.814
- Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol.1998; 10(3):384-391. https://doi.org/10.1016/S09550674(98)80015-X
- Morrison N, Harrap SB, Arriza JL, Boyd E, Connor JM.Regional chromosomal assignment of the human mineralocorticoid receptor gene to 4q31.1. Hum Genet. 1990;85(1):130–2. PMid:2162806. Available from: https://doi.org/10.1007/BF00276340
- Nichols M, Rientjes JM, Stewart AF. Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J. 1998; 17(3):765–73. PMid:9451001 PMCid:PMC1170425. Available from: https://doi.org/10.1093/emboj/17.3.765
- Novac N, Heinzel T. Nuclear Receptors: Overview and Classification. Current Drug Targets - Inflammation and Allergy. 2004; 3(4):339. Available from: https://doi.org/10.2174/1568010042634541
- Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y, Muramatsu M. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro.Biochem Biophys Res Commun. 1998; 243(1):122–6.Available from: https://doi.org/10.1006/bbrc.1997.7893 PMid:9473491
- Ortiz MA, Piedrafita FJ, Pfahl M, Maki R. TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Molecular Endocrinology.1995:9(12):1679–91. PMid:8614404. Available from: https://doi.org/10.1210/me.9.12.1679
- Otte K, Kranz H, Kober I, Thompson P, Hoefer M, Haubold B, Remmel B, Voss H, Kaiser C, Albers M, Cheruvallath Z, Jackson D, Casari G, Koegl M, Paabo S, Mous J, Kremoser C. Deuschle U. Identification of farnesoid X receptor β as a novel mammalian nuclear receptor sensing lanosterol.Mol Cell Biol. 2003; 23:864–72. PMid:12529392 PMCid: PMC140718. Available from: https://doi.org/10.1128/ MCB.23.3.864-872.2003
- Papetti M, Wood N, Lohmar PD, Bowman MR. The identification of the cDNA coding for HRR-1, a novel humanfarnesol receptor. Submitted (AUG-1996) to the EMBL/ GenBank/ DDBJ databases.
- Pe-a de Ortiz S, Cannon MM, Jamieson GA Jr. Expression of nuclear hormone receptors within the rat hippocampus: identification of novel orphan receptors. Brain Res Mol Brain Res. 1994; 23(3):278–83. Available from: https://doi.org/10.1016/0169-328X(94)90235-6
- Peters GA, Khan SA. Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP140. Mol Endocrinol. 1999; 13(2):286–96. PMid:9973258 Available from: https://doi.org/10.1210/mend.13.2.0244
- Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 1987; 330(6147):444–50. PMid:2825025.Available from: https://doi.org/10.1038/330444a0
- Pettersson K, Svensson K, Mattsson R, Carlsson B, Ohlsson R, Berkenstam A. Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis. Mech Dev. 1996; 54(2):211–23. Available from: https://doi.org/10.1016/0925-4773(95)00479-3
- Pignoni F, Baldarelli RM, Steingrímsson E, Diaz RJ, Patapoutian A, Merriam JR, Lengyel JA. The Drosophila gene tailless is expressed at the embryonic termini and is a member of the steroid receptor superfamily.Cell. 1990; 62(1):151–63. Available from: https://doi.org/10.1016/0092-8674(90)90249-E
- Prakash C, Zuniga B, Song CS, Jiang S, Cropper J, Park S, Chatterjee B. Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions. Nuc Receptor Res. 2015; 2.
- Qiu Y, Krishnan V, Zeng Z, Gilbert DJ, Copeland NG, Gibson L, Yang-Feng T, Jenkins NA, Tsai MJ, Tsai SY.. Isolation, characterization, and chromosomal localization of mouse and human COUP-TF I and II genes. Genomics. 1995; 29(1):240–46. PMid:8530078. Available from: https://doi.org/10.1006/geno.1995.1237
- Rana M, Devi S, Gourinath S, Goswami R, Tyagi RK. A comprehensive analysis and functional characterization of naturally occurring non-synonymous variants of nuclear receptor PXR. Biochim Biophys Acta. Available from: 2016; 1859(9):1183–97.
- Reitzel AM, Pang K, Ryan JF, Mullikin JC, Martindale MQ, Baxevanis AD, Tarrant AM. Nuclear receptors from the ctenophore Mnemiopsis leidyi lack a zinc-finger DNA-binding domain: lineage-specific loss or ancestral condition in the emergence of the nuclear receptor superfamily? Evodevo.Available from: 2011; 2(1):3. PMid:21291545 PMCid:PMC3038971.Available from: https://doi.org/10.1186/2041-9139-2-3
- Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.Nature. 1995; 378:681–9. PMid:7501014. Available from: https://doi.org/10.1038/378681a0
- Retnakaran R, Flock G, Giguère V. Identification of RVR, a novel orphan nuclear receptor that acts as a negative transcriptional regulator. Mol Endocrinol. 1994; 8(9):1234–44.PMid:7838156. Available from: https://doi.org/10.1210/ me.8.9.1234
- Robinson-Rechavi M, Carpentier AS, Duffraisse M, Laudet V. How many nuclear hormone receptors are there in the human genome? Trends Genet. 2001; 17(10):554–6. Available from: https://doi.org/10.1016/S0168-9525(01)02417-9
- Robinson-Rechavi M, Garcia HE, Laude V. The nuclear receptor Superfamily. Journal of Cell Science. 2003; 116:585– 6. PMid:12538758. Available from: https://doi.org/10.1242/ jcs.00247
- Romagnolo DF, Zempleni J, Selmin OI. Nuclear receptors and epi- genetic regulation: opportunities for nutritional targeting and dis- ease prevention. Advances in nutrition.2014; 5:373–85. PMid:25022987 PMCid:PMC4085186.Available from: https://doi.org/10.3945/an.114.005868
- Rousseau-Merck MF, Misrahi M, Loosfelt H, Milgrom E, Berger R. Localization of the human progesterone receptor gene to chromosome 11q22-q23. Hum Genet. 1987; 77(3):280–82. PMid:3679212. Available from: https://doi.org/10.1007/BF00284486
- Rowe A, Eager NS, Brickell PM. A member of the RXR nuclear receptor family is expressed in neural-crest-derived cells of the developing chick peripheral nervous system.Development. 1991; 111(3):771–8. PMid:1652422.
- Sap J, Mu-oz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennström B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature. 1986; 324(6098):635–40. PMid:2879242. Available from: https:// doi.org/10.1038/324635a0
- Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol. 1992; 6(10):1634– 41. PMid:1333051. Available from: https://doi.org/10.1210/ mend.6.10.1333051
- Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol. 1995; 9(1):72–85.PMid:7760852. Available from: https://doi.org/10.1210/ me.9.1.72
- Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science. 1996; 272(5266):1336–9. PMid:8650544. Available from: https:// doi.org/10.1126/science.272.5266.1336
- Sher T, Yi HF, McBride OW, Gonzalez FJ. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 1993; 32(21):5598-5604. PMid:7684926. Available from: https://doi.org/10.1021/bi00072a015
- Shi H, Shigeta H, Yang N, Fu K, O’Brian G, Teng CT. Human estrogen receptor-like 1 (ESRL1) gene: Genomic organization, chromosomal localization, and promoter characterization.Genomics. 1997: 44(1):52–60. PMid:9286700.Available from: https://doi.org/10.1006/geno.1997.4850
- Shinar DM, Endo N, Rutledge SJ, Vogel R, Rodan GA, Schmidt A. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor.Gene. 1994; 147(2):273–6. Available from: https://doi.org/10.1016/0378-1119(94)90080-9
- Siisens U, Borgmeyer U. Characterization of the human germ cell nuclear factor gene. Biochim Biophys Acta. 1996; 1309(3):179-182. Available from: https://doi.org/10.1016/ S0167-4781(96)00157-1
- Sladek FM, Ruse MD Jr, Nepomuceno L, Huang SM, Stallcup MR. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.Mol Cell Biol. 1999; 19(10):650922. PMid:10490591 PMCid: PMC84621. Available from: https://doi.org/10.1128/ MCB.19.10.6509
- Sladek FM. What are nuclear receptor ligands? MolCell Endocrinol.2011: 334:03–13.
- Sladek R, Beatty B, Squire J, Copeland NG, Gilbert DJ, Jenkins NA, Giguère V. Chromosomal mapping of the human and murine orphan receptors ERRalpha (ESRRA) and ERRbeta (ESRRB) and identification of a novel human ERRalpharelated pseudogene. Genomics. 1997; 45(2):320–6.PMid:9344655. https://doi.org/10.1006/geno.1997.4939
- Sluder AE, Maina CV. Nuclear receptors in nematodes: themes and variations. Trends in Genetics:TIG. 2001; 17(4):206–13. Available from: https://doi.org/10.1016/ S0168-9525(01)02242-9
- Smirnov AN. Nuclear receptors: nomenclature, ligands, mechanisms of their effects on gene expression. Biochemistry (Mosc). 2002; 67:957–77. Available from: https://doi.org/10.1023/A:1020545200302
- Smith DP, Mason CS, Jones EA, Old RW. A novel nuclear receptor superfamily member in Xenopus that associates with RXR, and shares extensive sequence similarity to the mammalian vitamin D3 receptor. Nucleic Acids Res. 1994; 22(1):66–71. PMid:8127656 PMCid:PMC307747. Available from: https://doi.org/10.1093/nar/22.1.66
- Song C, Kokontis JM, Hiipakka RA, Liao S. Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc Natl Acad Sci U S A. 1994; 91(23):10809–13. PMid:7971966 PMCid: PMC45115. Available from: https://doi.org/10.1073/ pnas.91.23.10809
- Spurr NK, Solomon E, Jansson M, Sheer D, Goodfellow PN, Bodmer WF, Vennstrom B. Chromosomal localisation of the human homologues to the oncogenes erb A and B.EMBO J. 1984; 3(1):159–63. PMid:6323162 PMCid:PMC557313.
- Szpirer J, Szpirer C, Riviere M, Levan G, Marynen P, Cassiman JJ, Wiese R, DeLuca HF. The Sp1 transcription factor gene (SP1) and the 1,25-dihydroxyvitamin D3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. Genomics. 1991; 11(1):168–73. Available from: https://doi.org/10.1016/0888-7543(91)90114-T
- Taymans SE, Pack S, Pak E, Orban Z, Barsony J, Zhuang Z, Stratakis CA. The human vitamin D receptor gene (VDR) is localized to region 12cen-q12 by fluorescent in situ hybridization and radiation hybrid mapping: genetic and physical VDR map. J Bone Miner Res. 1999; 14(7):1163–6. PMid:10404016. Available from: https://doi.org/10.1359/ jbmr.1999.14.7.1163
- Tchenio T, Segal-Bendirdjian E, Heidmann T. Generation of processed pseudogenes in murine cells. EMBO J. 1993; 12:1487–97. PMid:8385606 PMCid:PMC413361
- Theriault A, Boyd E, Harrap SB, Hollenberg SM, Connor JM. Regional chromosomal assignment of the human glucocorticoid receptor gene to 5q31. Hum Genet. 1989; 83(3):289–91. PMid:2793174. Available from: https://doi.org/10.1007/BF00285175
- Tian Y. Epigenetic regulation of pregnane X receptor activity.Drug Metab Rev. 2013; 45(2):166–72. PMid:23600685.Available from: https://doi.org/10.3109/03602532.2012.756 012
- Torii T, Kawarai T, Nakamura S, Kawakami H. Organization of the human orphan nuclear receptor Nurr1 gene.Gene. 1999; 230(2):225–32. Available from: https://doi.org/10.1016/s0378-1119(99)00064-5
- Tsai MJ, O’Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994; 63:451–86. PMid:7979245. Available from:https://doi.org/10.1146/annurev.bi.63.070194.002315
- Tyagi RK, Amazit L, Lescop P, Milgrom E, Guiochon-Mantel A. Mechanisms of Progesterone Receptor Export from Nuclei: Role of Nuclear Localization Signal, Nuclear Export Signal, and Ran Guanosine Triphosphate. Molecular Endocrinology.1998; 12(11):1684–94. PMid:9817595. Available from: https://doi.org/10.1210/mend.12.11.0197
- Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. A structural role for hormone in the thyroid hormone receptor. Nature. 1995; 378(6558):690–7. PMid:7501015. Available from: https:// doi.org/10.1038/378690a0
- Wang LH, Tsai SY, Cook RG, Beattie WG, Tsai MJ, O’Malley BW. COUP transcription factor is a member of the steroid receptor superfamily. Nature. 1989; 340(6229):163–6. PMid:2739739. Available from: https:// doi.org/10.1038/340163a0
- Wärnmark A, Treuter E, Wright AP, Gustafsson J. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol.2003; 17:10. PMid:12893880. Available from: https://doi.org/10.1210/me.2002-0384
- Weinberger C, Hollenberg SM, Rosenfeld MG, Evans RM.Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature.1985; 318(6047):670–2. PMid:3841189. Available from: https://doi.org/10.1038/318670a0
- Weinberger C, Thompson C, Ong E, Gruol D, Evans R. The c-erbA gene encodes a thyroid hormone receptor. Nature.1986; 324:641–6. PMid:2879243. Available from: https:// doi.org/10.1038/324641a0
- Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995; 9(9):1033–45. PMid:7744246. Available from: https://doi.org/10.1101/gad.9.9.1033
- Wong M, Ramayya MS, Chrousos GP, Driggers PH, Parker KL. Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J Mol Endocrinol. 1996; 17(2):139–47. PMid:8938589. Available from: https://doi.org/10.1677/jme.0.0170139
- Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature.1996; 384(6608):458–60. Available from: https://doi.org/10.1038/384458a0
- Yoshikawa T, Brkanac Z, Dupont BR, Xing GQ, Leach RJ, Detera-Wadleigh SD. Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2. Genomics. 1996; 35(3):637–8.PMid:8812511. Available from: https://doi.org/10.1006/ geno.1996.0417
- Yoshikawa T, DuPont BR, Leach RJ, Detera-Wadleigh SD. New variants of the human and rat nuclear hormone receptor, TR4: expression and chromosomal localization of the human gene. Genomics. 1996a; 35(2):361–6.PMid:8661150. https://doi.org/10.1006/geno.1996.0368
- Yu RT, McKeown M, Evans RM, Umesono K. Relationship between Drosophila gap gene tailless and a vertebrate nuclear receptor Tlx. Nature. 1994; 370(6488):375– 9. PMid:8047143. Available from: https://doi.org/10.1038/370375a0
- Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Näär AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG.RXR beta: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell. 1991; 67(6):1251–66. Available from: https://doi.org/10.1016/0092-8674(91)90301-E
- Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, Lalli E, Moser C, Walker AP, McCabe ER, et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita.Nature. 1994; 372(6507):635–41. PMid:7990953. Available from: https://doi.org/10.1038/372635a0
- Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther.2013; 138:103–41. PMid:23333322. Available from: https:// doi.org/10.1016/j.pharmthera.2012.12.007
- Zhang Z, Burch PE, Cooney AJ, Lanz RB, Pereira FA, Wu J, Gibbs RA, Weinstock G, Wheeler DA. Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. Genome Res.2004; 14(4):580–90. PMid:15059999 PMCid:PMC383302.Available from: https://doi.org/10.1101/gr.2160004
- Zhi X, Zhou XE, Melcher K, Xu HE. Structures and regulation of non-X orphan nuclear receptors: A retinoid hypothesis. J Steroid Biochem Mol Biol. 2016; 157:27–40.PMid:26159912. Available from: https://doi.org/10.1016/j.jsbmb.2015.06.012
- Thiazolidinedione Class of Anti-Diabetic Drugs Modulate Nuclear Receptor CAR Function
Abstract Views :244 |
PDF Views:1
Authors
Affiliations
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University New Delhi – 110067, IN
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University New Delhi – 110067, IN
Source
Journal of Endocrinology and Reproduction, Vol 21, No 1 (2017), Pagination: 27-34Abstract
The human body has developed a defence system to prevent the accumulation of endogenous (bile acids, steroids, cholesterol metabolites, neurotransmitters, etc.) as well as exogenous (xenobiotics, clinical drugs, etc.) small molecules at toxic levels. This task is accomplished by ‘drug metabolism and disposition (DMD) machinery’ which entails phase I and phase II enzymes, and phase III transporter proteins. The components of this machinery act in a coordinated manner to biotransform and facilitate the elimination of small toxic molecules from the cellular milieu. Constitutive androstane receptor (CAR), a member of the nuclear receptor superfamily, acts as one of the major transcriptional regulators of the DMD machinery. Prescription of combination therapy is a common regimen during the treatment of diverse metabolic disorders and infectious diseases. In such combination therapies one drug may modulate the expression of genes of DMD, influencing the metabolism of another co-administered drug. This leads to decreased bioavailability or increased toxicity of the latter. Evaluation of drug-drug interactions (DDIs) has now become a major safety concern during drug discovery and development processes. Pre-assessment of the small molecules for modulatory effects on CAR and induction of the components of DMD can resolve the safety concerns, treatment failures and drug withdrawals due to the harmful DDIs. In the present study, we have followed a ‘reverse approach’ to assess CAR activation by drugs previously withdrawn from clinical practices. We selected three redundant members of thiazolidinedione family of anti-diabetic drugs and examined their potential in regulation of CAR and its target gene CYP2B6. These drugs showed differential transcriptional activation of CAR. Two of the TZD i.e., rosiglitazone and pioglitazone enhanced CAR activity by behaving as receptor ligands while the other (troglitazone) did not influence the receptor function and was justly withdrawn since it inflicted cytotoxicity.Keywords
Anti-Diabetic Drugs, Constitutive Androstane Receptor, Drug Metabolism and Disposition Machinery, Nuclear Receptor, Nuclear Translocation.References
- Baes M, Gulick T, Choi H–S, Martinoli MG, Simha D, Moore DD. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol. 1994; 14(3):1544–52. PMid:8114692 PMCid:PMC358513
- Chang TKH. Activation of pregnane x receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines. AAPS J. 2009; 11(3):590–601. PMid:19688601. Available from: https://doi.org/10.1208/s12248–0099135–y.
- Chaturvedi NK, Kumar S, Negi S, Tyagi RK. Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor:potential implications in metabolic disorders. Mol Cell Biochem. 2010; 345(1–2):291–308. PMid:20830510. Available from: https://doi.org/10.1007/s11010–010–0583–6.
- Dash AK, Yende AS, Kumar S, Singh, SK, Kotiya D, Rana M et al. The Constitutive Androstane Receptor (CAR): a nuclear receptor in health and disease. J Endocrinol Reprod. 2014; 18(2):59–74.
- Dash AK, Tyagi RK. A compendium of nuclear receptors: The superfamily of ligand–modulated transcription factors. J Endocrinol Reprod. 2016; 20(1):1–27.
- Dash AK, Yende AS, Tyagi RK. Novel application of red fluorescent protein (DsRed–Express) for the study of functional dynamics of nuclear receptors. J Fluoresc. 2017; 27(4):1225–1231. PMid:28470379. Available from: https://doi.org/10.1007/s10895–017–2109–z.
- Dong B, Saha PK, Huang W, Chen W, Abu–Elheiga LA, Wakil SJ et al. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA. 2009; 106(44):18831–6. PMid:19850873. Available from: https://doi.org/10.1073/pnas.0909731106.
- Ducharme MP, Bernstein ML, Granvil CP, Gehrcke B, Wainer IW. Phenytoin–induced alteration in the N–dechloroethylation of ifosfamide stereoisomers. Cancer Chemother Pharmacol. 1997; 40(6):531–533. PMid:9332469. Available from: https://doi.org/10.1007/s002800050698.
- Gao J, Xie W. Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol Sci. 2012; 33(10):552–8. PMid:22889594. Available from: https://doi.org/10.1016/j.tips.2012.07.003.
- Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the Nuclear Receptor superfamily. Nat Rev Drug Discov. 2004; 3(11):950–64. PMid:15520817. Available from: https://doi.org/10.1038/nrd1551.
- Huang SM, Temple R, Throckmorton DC, Lesko LJ. Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther. 2007; 81(2):298–304. PMid: 17259955. Available from: https://doi.org/10.1038/sj.clpt.6100054.
- Huang W, Zhang J, Wei P, Schrader WP, Moore DD. Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol Endocrinol. 2004; 18(10):2402–2408. PMid:15272053. Available from: https://doi.org/10.1210/me.2004–0046.
- Kaiser D, Oetjen E. Something old, something new and something very old: drugs for treating type 2 diabetes. Br J Pharmacol. 2014; 171(12):2940–50. PMid:24641580. Available from: https://doi.org/10.1111/bph.12624.
- Kumar S, Saradhi M, Chaturvedi NK, Tyagi RK. Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: An overview. Mol Cell Endocrinol. 2006; 246(12):147–56. PMid:16388893. Available from: https://doi.org/10.1016/j.mce.2005.11.028.
- Levin D, Bell S, Sund R, Hartikainen SA, Tuomilehto J, Pukkala E et al. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis. Diabetologia. 2015; 58(3):493–504. PMid:25481707. Available from: https://doi.org/10.1007/s00125–014–3456–9.
- Lim PLK, Liu J, Go ML, Boelsterli UA. The mitochondrial superoxide/thioredoxin–2/ask1 signaling pathway is critically involved in troglitazone–induced cell injury to human hepatocytes. Toxicol Sci. 2008; 101(2):341–349. PMid:17975114. Available from: https://doi.org/10.1093/toxsci/kfm273.
- Mackowiak B, Wang H. Mechanisms of xenobiotic receptor activation: Direct vs. indirect. Biochim Biophys Acta. 2016; 1859(9):1130–1140. PMid:26877237. Available from: https://doi.org/10.1016/j.bbagrm.2016.02.006.
- Nakajima M, Komagata S, Fujiki Y, Kanada Y, Ebi H, Itoh K. Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/ pharmacodynamics of cyclophosphamide in Japanese cancer patients. Pharmacogenet Genom. 2007; 17(6):431–45. PMid:17502835. Available from: https://doi.org/10.1097/FPC.0b013e328045c4fb.
- Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007; 356(24):2457–2471. PMid: 17517853. Available from: https://doi.org/10.1056/ NEJMoa072761.
- Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta–analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med. 2010; 170(14):1191–1201. PMid:20656674. Available from: https://doi.org/ 10.1001/archinternmed.2010.207.
- Prakash C, Zuniga B, Song CS, Jiang S, Cropper J, Park S et al. Nuclear receptors in drug metabolism, drug response and drug interactions. Nucl Receptor Res. 2015; 2:101178. PMCid:PMC4963026.
- Rana M, Devi S, Gourinath S, Goswami R, Tyagi RK. A comprehensive analysis and functional characterization of naturally occurring non–synonymous variants of nuclear receptor PXR. Biochim Biophys Acta. 2016; 1859(9):1183–97. PMid:26962022. Available from: https://doi.org/10.1016/j.bbagrm.2016.03.001.
- Staudinger JL, Lichti K. Cell signaling and nuclear receptors: New opportunities for molecular pharmaceuticals in liver disease. Mol Pharm. 2008; 5(1):17–34. PMid:18159925. Available from: https://doi.org/10.1021/mp700098c.
- Taylor C, Hobbs FR. Type 2 diabetes, thiazolidinediones and cardiovascular risk. Br J Gen Pract. 2009; 59(564):520–524. PMid:19567003. Available from: https://doi.org/10.3399/bjgp09X453440
- Vitamin D Receptor in Human Health and Disease: An Overview
Abstract Views :141 |
PDF Views:0
Authors
Affiliations
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi - 110067, IN
1 Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi - 110067, IN
Source
Journal of Endocrinology and Reproduction, Vol 26, No 1 (2022), Pagination: 01-23Abstract
Vitamin D Receptor (VDR) is a key regulator of bone metabolism and calcium homeostasis. Various investigations suggest its association with many life-threatening diseases including bone-related disorders, cancers, diabetes, cardiovascular diseases, infectious diseases and metabolic disorders. VDR forms a heterodimeric complex with Retinoid X Receptor (RXR) when activated with 1α,25-dihydroxyvitamin D3 and binds to vitamin D response elements (VDREs) in the DNA sequences located upstream of target genes. Ligand binding and heterodimerization play critical roles in receptor activation and gene regulation. Many studies have shown that any change in VDR function influences target gene functions. Numerous VDR polymorphisms have been reported in various populations around the world. Additionally, a number of case-control studies have established a link between the VDR polymorphism(s) and human diseases. However, some contradictory studies have also been reported. Recent investigations have identified several critical VDR polymorphism(s) that may influence or alter the receptor’s function and contribute to the genesis/etiology of disease states. In this review, we have highlighted and analyzed the relevance of VDR and its polymorphism(s) vis-a-vis risk to some disease conditions. The current review highlights the importance of VDR-SNPs in decoding the importance of a receptor as a transcription factor as well as a molecular marker for diagnosis of diverse health conditions.Keywords
Nuclear Receptors, Polymorphism, Retinoid X Receptor, Transcription Factors, Vitamin D Receptor.References
- Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: Opening the X-files. Science. 2001; 294(5548):1866-70. https://doi.org/10.1126/science.294.5548.1866. PMid:11729302.
- Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys. 2012; 523(1):123-33. https://doi.org/10.1016/j. abb.2012.04.001. PMid:22503810.
- Uitterlinden AG, Fang Y, van Meurs JBJ, et al., Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J Steroid Biochem Mol Biol. 2004; 89-90:187-93. https://doi.org/10.1016/j.jsbmb.2004.03.083. PMid:15225770.
- Baker AR, McDonell DP, Hughes M, et al., Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U.S.A. 1998; 85:3294-8. https://doi.org/10.1073/pnas.85.10.3294. PMid:2835767 PMCid:PMC280195.
- Issa LL, Leong GM,. Eisman JA. Molecular mechanism of vitamin D receptor action. Inflamm Res. 1998; 47:451-475. https://doi.org/10.1007/s000110050360. PMid:9892040.
- Black BE, Holaska JM, Rastinejad F, Paschal BM. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol. 2001; 11:1749-58. https://doi.org/10.1016/S0960-9822(01)00537-1.
- Prufer K, Barsony J. Retinoid X Receptor Dominates the Nuclear Import and Export of the Unliganded Vitamin D Receptor. Mol Endocrinol. 2002; 16:1738-51. https://doi.org/10.1210/me.2001-0345. PMid:12145331. 8. Pike JW. The Vitamin D Receptor: Discovery, Structure, and Function. Adv Organ Biol. 1998; 5:213-41. https://doi.org/10.1016/S1569-2590(08)60114-7.
- Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014; 21:319-29. https://doi.org/10.1016/j.chembiol.2013.12.016. PMid:24529992 PMCid:PMC3968073.
- Hourai S, Rodrigues LC, Antony P, et al., Structure-Based Design of a Superagonist Ligand for the Vitamin D Nuclear Receptor. Chem Biol. 2008; 15:383-92. https://doi.org/10.1016/j.chembiol.2008.03.016. PMid:18420145.
- Antony P, Sigueiro R, Huet T, et al., Structure-function relationships and crystal structures of the vitamin D receptor bound 2α-methyl-(20S,23S) and 2α-methyl-(20S,23R)-epoxymethano-1α,25-dihydroxyvitamin D3. J Med Chem. 2010; 53:1159-71. https://doi.org/10.1021/jm9014636. PMid:20070104.
- EelenG, Valle N, Sato Y, et al., Superagonistic Fluorinated Vitamin D3 Analogs Stabilize Helix 12 of the Vitamin D Receptor. Chem Biol. 2008; 15:1029-34. https://doi.org/10.1016/j.chembiol.2008.08.008. PMid:18940664.
- Eelen G, Verlinden L, Bouillon R, et al., CD-ring modified vitamin D3 analogs and their superagonistic action. J Steroid Biochem Mol Biol. 2010; 121:417-19. https://doi.org/10.1016/j.jsbmb.2010.01.010. PMid:20132886. 14. Tavera-Mendoza L, Wang TT, Lallemant B, et al., Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep. 2006; 7:180-85. https://doi.org/10.1038/sj.embor.7400594. PMid:16322758 PMCid:PMC1369248.
- Malloy PJ, Feldman D. Vitamin D resistance. Am J Med. 1999; 106:355-70. https://doi.org/10.1016/S0002-9343(98)00419-7.
- Kittaka A, Saito N, Honzawa S, et al., Creative synthesis of novel vitamin D analogs for health and disease. J Steroid Biochem Mol Biol. 2007; 103:269-76. https://doi.org/10.1016/j.jsbmb.2006.12.002. PMid:17223554.
- Dixon KM, Deo SS, Wong G, et al., Skin cancer prevention: a possible role of 1,25-dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol. 2005; 97:137-43. https://doi.org/10.1016/j.jsbmb.2005.06.006. PMid:16039116.
- Peleg S, Peterson KS, Suh BC, et al., Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1 alpha, 25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation. J Med Chem. 2006; 49:7513-17. https://doi.org/10.1021/jm0609925. PMid:17149880.
- De Clercq PJ, Buysser FD, Minne G, et al., The development of CD-ring modified analogs of 1 alpha,25- dihydroxyvitamin D. J Steroid Biochem Mol Biol. 2007; 103:206-12. https://doi.org/10.1016/j.jsbmb.2006.12.023. PMid:17218098.
- Carlberg C, Molnar F, Mourino A. Vitamin D receptor ligands: the impact of crystal structures. Expert Opin Ther Pat. 2012;22:417-35. https://doi.org/10.1517/13543776.2012.673590. PMid:22449247.
- Sokolowska K, Mourino A, Sicinski RR, et al., Synthesis and biological evaluation of 6-methyl analog of 1 alpha,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2010; 121:29-33. https://doi.org/10.1016/j.jsbmb.2010.02.008. PMid:20153829.
- Sawada D, Tsukuda Y, Saito H, et al., Development of 14-epi-19-nortachysterol and its unprecedented binding configuration for the human vitamin D receptor. J Am Chem Soc. 2011; 133:7215-21. https://doi.org/10.1021/ja201481j. PMid:21500802.
- Carlberg C, Molnar F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. Curr Top Med Chem. 2006; 6:1243-53. https://doi.org/10.2174/156802606777864908. PMid:16848738.
- Zhao XY, Eccleshall TR, Krishnan AV, et al., Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system. Mol Endocrinol. 2014; 11:366-78. https://doi.org/10.1210/mend.11.3.9895. PMid:9058382.
- Hsieh JC, Jurutka PW, Selznick SH, et al., The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation. Biochem Biophys Res Commun. 1995; 215:1-7. https://doi.org/10.1006/bbrc.1995.2426. PMid:7575575.
- Whitfield GK, Hseih JC, Nakajima S, et al., A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol Endocrinol. 2014; 9:1166-79. https://doi.org/10.1210/mend.9.9.7491109.
- Clemens TL, Garrett KP, Zhou XY, et al., Immunocytochemical localization of the 1,25-dihydroxyvitamin d3 receptor in target cells. Endocrinology. 1988; 122:1224-30. https://doi.org/10.1210/endo-122-4-1224. PMid:2831024.
- Hunziker W, Walters MR, Bishop JE, Norman AW. Unoccupied and in vitro and in vivo occupied 1,25-dihydroxyvitamin D3 intestinal receptors. Multiple biochemical forms and evidence for transformation. J Biol Chem. 1983; 258:8642-48. https://doi.org/10.1016/S0021-9258(18)32105-7.
- Berger U, Wilson P, McClelland RA, et al., Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988; 67:607-13 . https://doi.org/10.1210/jcem-67-3-607. PMid:2842365.
- Luo Z, Rouvinen J, Mäenpää PH. A peptide C-terminal to the second Zn finger of human vitamin D receptor is able to specify nuclear localization. Eur J Biochem. 1994; 223:381-87. https://doi.org/10.1111/j.1432-1033.1994.tb19004.x. PMid:8055906.
- Hsieh JC, Shimizu Y, Minoshima S, et al., Novel nuclear localization signal between the two DNA-binding zinc fingers in the human vitamin D receptor. J Cell Biochem. 1998; 70:94-109. https://doi.org/10.1002/(SICI)1097-4644(19980701)70:1<94::AID-JCB10>3.0.CO;2-B.
- Michigami T, Suga A, Yamazaki M, et al., Identification of amino acid sequence in the hinge region of human vitamin D receptor that transfers a cytosolic protein to the nucleus. J Biol Chem. 1999; 274:33531-38. https://doi.org/10.1074/jbc.274.47.33531. PMid:10559238.
- Yasmin R, Williams RM, Xu M, Noy N. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J Biol Chem. 2005; 280:40152-60. https://doi.org/10.1074/jbc.M507708200. PMid:16204233.
- Dash AK, Yende AS, Tyagi RK. Novel application of red fluorescent protein (dsred-express) for the study of functional dynamics of nuclear receptors. J Fluoresc. 2017; 27:1225-31. https://doi.org/10.1007/s10895-017-2109-z. PMid:28470379.
- Kumar S, Kashyap J, Thakur K, Tyagi RK. A Simple method for visual assessment and quantification of altered subcellular localization of nuclear receptors. Nuclear Receptors. 2021. p. 23-36. https://doi.org/10.1007/978-3-030-78315-0_2.
- Civitelli R, Ziambaras K. Calcium and phosphate homeostasis: concerted interplay of new regulators. J Endocrinol Invest. 2011; 34:3-7.
- Saito H, Maeda A, Ohtomo S, et al., Circulating FGF-23 is regulated by 1 alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem. 2005; 280:2543-49. https://doi.org/10.1074/jbc.M408903200. PMid:15531762.
- Meyer MB, Watanuki M, Kim S, et al., The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin d receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in Intestinal cells. Mol Endocrinol. 2006; 20:1447-61. https://doi.org/10.1210/me.2006-0031. PMid:16574738.
- Kim S, Yamazaki M, Zella LA, et al., Activation of receptor activator of nf- b ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol Cell Biol. 2006; 26(17):6469-86. https://doi.org/10.1128/MCB.00353-06. PMid:16914732 PMCid:PMC1592822.
- Wang QM, Jones JB, Studzinski GP. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 1996; 56:264-67.
- Verlinden L, Verstuyf A, Convents R, et al., Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol Cell Endocrinol. 1998; 142:57-65. https://doi.org/10.1016/S0303-7207(98)00117-8.
- Peng L, Malloy PJ, Feldman D. Identification of a Functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol Endocrinol. 2004; 18:1109-19. https://doi.org/10.1210/me.2003-0344. PMid:14963110.
- Gil A, Plaza-Diaz J, Mesa MD. Vitamin D: Classic and novel actions. Ann Nutr Metab. 2018; 72:87-95. https://doi.org/10.1159/000486536. PMid:29346788.
- Jones G, Strugnell SA, Deluca HF. Current understanding of the molecular actions of vitamin D physiol rev. 1998; 78:1193-231. https://doi.org/10.1152/physrev.1998.78.4. 1193.PMid:9790574.
- Pike J.W, Meyer MB, Lee SM, et al., The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights. J Clin Invest. 2017; 127:1146-54. https://doi.org/10.1172/JCI88887. PMid:28240603 PMCid:PMC5373853.
- Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005; 26:662-87. https://doi.org/10.1210/er.2004-0002. PMid:15798098.
- Carlberg C, Seuter S, Heikkinen S. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res. 2012; 282:271-82.
- Ryan JW, Anderson PH, Morris HA. Pleiotropic activities of vitamin D receptors- Adequate activation for multiple health outcomes. Clin Biochem Rev. 2015; 36:53-61.
- Jeon S. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018; 50(4):1-14. https://doi.org/10.1038/s12276-018-0038-9. PMCid:PMC5938036.
- Gross C, Eccleshall TR, Malloy PJ, et al., The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal mexican-American women. J Bone Miner Res. 1996; 11:1850-55. https://doi.org/10.1002/jbmr.5650111204. PMid:8970885.
- Taylor JA, Hirvonen A, Watson M, et al., Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996; 56:4108-10.
- Li L, Wu B, Liu J, Yang L. Vitamin D receptor gene polymorphisms and type 2 diabetes : Arch Med Res. 2013; 44:235-41. https://doi.org/10.1016/j.arcmed.2013.02.002. PMid:23506721.
- Huang L, Liu C, Liao G, et al., Vitamin D receptor gene foki polymorphism contributes to increasing the risk of tuberculosis: An update meta-Analysis. Medicine (Baltimore). 2015;94:1-8. https://doi.org/10.1097/MD.0000000000002256. PMid:26705207 PMCid:PMC 4697973.
- Laplana M, Royo JL, Fibla J. Vitamin D receptor polymorphisms and risk of enveloped virus infection: A meta-analysis. Gene. 2018; 678:384-94. https://doi.org/10.1016/j.gene.2018.08.017. PMid:30092343.
- Saijo T, Ito M, Takeda E, Huq AHMM, et al., A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet. 1991; 49: 668-73.
- Arai H, Miyamoto K, Taketani Y, et al., A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997; 12:915-21. https://doi.org/10.1359/jbmr.1997.12.6.915. PMid:9169350.
- Gross C, Krishnan AV, Malloy PJ, et al., The vitamin D receptor gene start codon polymorphism: A functional analysis of FokI variants. J Bone Miner Res. 1998; 13:1691-99. https://doi.org/10.1359/jbmr.1998.13.11.1691. PMid:9797477.
- Yamamoto H, Miyamoto K, Li B, et al., The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res. 1999; 14:240-247. https://doi.org/10.1359/jbmr.1999.14.2.240. PMid:9933478.
- Arai H, Miyamoto KI, Yoshida M, et al., The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res. 2001; 16:1256-64. https://doi.org/10.1359/jbmr.2001.16.7.1256. PMid:11450701.
- Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of transacting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci. 1992; 89:6665-69. https://doi.org/10.1073/pnas.89.15.6665. PMid:1353882 PMCid:PMC49563.
- Faraco JH, Morrison NA, Baker A, et al., ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res. 1989; 17:2150. https://doi.org/10.1093/nar/17.5.2150. PMid:2564666 PMCid:PMC317576.
- Farrow S. Allelic variation and the vitamin D receptor. Lancet. 1994; 343:1242. https://doi.org/10.1016/S0140-6736(94)92147-4.
- Fang Y, Van Meurs JB, D’Alesio, A, et al., Promoter and 3′-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: The rotterdam study. Am J Hum Genet. 2005; 77:807-23. https://doi.org/10.1086/497438. PMid:16252240 PMCid:PMC1271389.
- Halsall JA, Osborne JE, Potter L, et al., A novel polymorphism in the IA promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma. Br J Cancer. 2004; 91:765-70. https://doi.org/10.1038/sj.bjc.6602006. PMid:15238985 PMCid:PMC2364794.
- Ye WZ, Reis AF, Velho G. Identification of a novel Tru9 I polymorphism in the human vitamin D receptor gene. J Hum Genet. 2000; 45:56-57. https://doi.org/10.1007/s100380050011. PMid:10697965.
- John EM, Schwartz GG, Koo J, et al., Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol. 2007; 166:1409-19. https://doi.org/10.1093/aje/kwm259. PMid:17934201.
- Morrison NA, Qi JC, Tokita A, et al., Prediction of bone density from vitamin D receptor alleles. Nature. 1994; 367:284-87. https://doi.org/10.1038/367284a0. PMid:8161378.
- Uitterlinden AG, Pols HA, Burger H, et al., A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res. 1996; 11:1241-48. https://doi.org/10.1002/jbmr.5650110908. PMid:8864898.
- Tokitan A, Matsumoto H, Morrison NA, et al., Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res. 1996; 11:1003-09. https://doi.org/10.1002/jbmr.5650110718. PMid:8797122.
- McClure L, Eccleshall TR, Gross C, et al., Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women. J Bone Miner Res.1997; 12:234-40. https://doi.org/10.1359/jbmr.1997.12.2.234. PMid:9041055.
- Tsai KS, Hsu SH, Cheng WC, et al., Bone mineral density and bone markers in relation to vitamin D receptor gene polymorphisms in Chinese men and women. Bone. 1996; 19:513-18. https://doi.org/10.1016/S8756-3282(96)00228-1.
- Lundin AC, Soderkvist P, Eriksson B, et al., Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res. 1999; 59:2332-34.
- Cicek MS, Liu X, Schumacher FR, et al., Vitamin D receptor genotypes/haplotypes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2006; 15:2549-52. https://doi.org/10.1158/1055-9965.EPI-06-0409. PMid:17164384.
- Correa-Cerro L, Berthon P, Haussler J, et al., Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet. 1999; 105:281-87. https://doi.org/10.1007/s004399900119. PMid:10987658.
- Cheteri MB, Stanford JL, Friedrichsen DM, et al., Vitamin D receptor gene polymorphisms and prostate cancer risk. Prostate. 2004; 59:409-18. https://doi.org/10.1002/pros.20001. PMid:15065089.
- Von Schuckmann LA, Law MH, Montgomery GW, et al., Vitamin D pathway gene polymorphisms and keratinocyte cancers: A nested case-control study and meta-analysis. Anticancer Res. 2016; 36:2145-52.
- Lee YH, Gyu Song G. Vitamin D receptor FokI, BsmI, TaqI, ApaI, and EcoRV polymorphisms and susceptibility to melanoma: A meta-analysis. J BUON. 2015; 20:235-43.
- Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 2007; 28:390-97. https://doi.org/10.1093/carcin/bgl156. PMid:16950800.
- Hutchinson PE, Osborne JE, Lear JT, et al., Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res. 2000; 6:498-504.
- Hajj A, Chedid R, Chouery E, et al., Relationship between vitamin D receptor gene polymorphisms, cardiovascular risk factors and adiponectin in a healthy young population. Pharmacogenomics. 2016; 17:1675-86. https://doi.org/10.2217/pgs-2016-0045. PMid:27672714.
- He L, Wang M. Association of vitamin D receptor- A gene polymorphisms with coronary heart disease in Han Chinese. Int J Clin Exp Med. 2015; 8:6224-29.
- Alizadeh S, Djafarian K, Alizadeh H, et al., Common variants of Vitamin D receptor gene polymorphisms and susceptibility to coronary artery disease: A systematic review and meta-Analysis. J Nutrigenet Nutrigenomics. 2017; 10:9-18. https://doi.org/10.1159/000455914. PMid: 28351026.
- Bhalla AK, Amento EP, Serog B., Glimcher LH. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol. 1984; 133:1748-54.
- Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev. 1994; 15:516-42. https://doi.org/10.1210/edrv-15-4-516. PMid:7988484.
- Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 1995; 53:599-602. https://doi.org/10.1016/0960-0760(95)00106-A.
- Norman AW. The vitamin D endocrine system: identification of another piece of the puzzle. Endocrinology. 1994; 134:1601A-1601C. https://doi.org/10.1210/endo.134.4. 8137720. PMid:8137720.
- McDermott MF, Ramachandran A, Ogunkolade BW, et al., Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia. 1997; 40:971-75. https://doi.org/10.1007/s001250050776. PMid:9267994.
- Motohashi Y, Yamada S, Yanagawa T, et al., Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab. 2003; 88:3137-40. https://doi.org/10.1210/jc.2002-021881. PMid:12843155.
- Nejentsev S, Cooper JD, Godfrey L, et al., Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes. Diabetes. 2004; 53:2709-12. https://doi.org/10.2337/diabetes.53.10.2709. PMid:15448105.
- Angel B, Santos JL, Carrasco E, et al., Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: A case-parent study. Eur J Epidemiol. 2004; 19:1085-87. https://doi.org/10.1007/s10654-004-1026-z. PMid:15678787.
- Chang TJ, Lei HH, Yeh JI, et al., Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol. 2000; 52:575-80. https://doi.org/10.1046/j.1365-2265.2000. 00985.x. PMid:10792336.
- Turpeinen H, Hermann R, Vaara S, et al., Vitamin D receptor polymorphisms: No association with type 1 diabetes in the Finnish population. Eur J Endocrinol. 2003; 149:591-96. https://doi.org/10.1530/eje.0.1490591. PMid:14641002.
- Fathy WM, Tawfeek GA, Tawfeek AR, Aboelyazeid SM. Vitamin D receptor ( BsmI ) gene polymorphism and type 2 diabetes mellitus in an Egyptian population. Menoufia Med J. 2018; 31:557-63.
- Ortlepp JR, Lauscher J, Hoffmann R, et al., The vitamin D receptor gene variant is associated with the prevalence of Type 2 diabetes mellitus and coronary artery disease. Diabet Med. 2001; 18:842-45. https://doi.org/10.1046/j.1464-5491.2001.00585.x. PMid:11678976.
- Hitman GA, Mannan N, McDermott MF, et al., Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes. 1998; 47:688-90. https://doi.org/10.2337/diabetes.47.4.688. PMid:9568705.
- Ye WZ, Reis AF, Dubois-Laforgue D, et al., Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol. 2001; 145:181-86. https://doi.org/10.1530/eje.0.1450181. PMid:11454514.
- Gnanaprakash V, Bodhini D, Kanthimathi S, et al., Association of Vitamin D receptor (TaqI, BsmI, and FokI) polymorphisms with prediabetes and Type 2 diabetes in Asian Indians. J Diabetol. 2019; 10: 29-36. https://doi.org/10.4103/jod.jod_14_18.
- Nosratabadi R, Arababadi MK, Salehabad VA. Vitamin D Receptor Polymorphisms in Type 2 Diabetes in Southeastern Iranian Patients. Lab Med. 2011; 42:32-34 https://doi.org/10.1309/LMW788XEEYVVLBUV.
- Angel B, Lera L, Márquez C, Albala C. The association of VDR polymorphisms and type 2 diabetes in older people living in community in Santiago de Chile. Nutr Diabetes. 2018; 8:31. https://doi.org/10.1038/s41387-018-0038-9. PMid:29795525 PMCid: PMC5968031.
- Roth DE, Soto G, Arenas F, et al., Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis. 2004; 190: 920-27. https://doi.org/10.1086/423212. PMid:15295697.
- Roy S, Frodsham A, Saha B, et al., Association of vitamin D Receptor genotype with leprosy type. J Infect Dis. 1999; 179: 187-91. https://doi.org/10.1086/314536. PMid:9841838.
- Goulart LR, Ferreira FR, Goulart IMB. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. FEMS Immunol Med Microbiol. 2006; 48:91-98. https://doi. org/10.1111/j.1574-695X.2006.00128.x. PMid:16965356.
- Mahyar A, Ayazi P, Afshar AS, et al., Vitamin D receptor gene (FokI, TaqI, BsmI, and ApaI) polymorphisms in children with urinary tract infection. Pediatr Res. 2018; 84:527-32. https://doi.org/10.1038/s41390-018-0092-y. PMid:29976973.
- Simmons JD, Mullighan C, Welsh KI, et al., Vitamin D receptor gene polymorphism: Association with Crohn’s disease susceptibility. Gut. 2000; 47:211-14. https://doi.org/10.1136/gut.47.2.211. PMid:10896912 PMCid:PMC1728007.
- Leon Rodriguez DA, Carmona FD, González CI, Martin J. Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy. Sci Rep. 2016; 6:1-6. https://doi.org/10.1038/srep31263. PMid:27502545 PMCid:PMC4977507.
- Martins DJ, Matos GC, Loiola RS, et al., Relationship of vitamin D receptor gene polymorphisms in Helicobacter pylori gastric patients. Clin Exp Gastroenterol. 2018; 12:19-27. https://doi.org/10.2147/CEG.S143332. PMid:29391820 PMCid:PMC5769596.
- Bellamy R, Ruwende C, Corrah T et al., Tuberculosis and chronic Hepatitis B virus infection in africans and variation in the vitamin D receptor gene. J Infect Dis. 2002; 179:721-24. https://doi.org/10.1086/314614. PMid:9952386.
- Torres C, Sanchez-de-la-Torre M, Garcia-Moruja C, et al., Immunophenotype of Vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression. Curr HIV Res. 2010; 8:487-92. https://doi.org/10.2174/157016210793499330. PMid:20642435.
- Han WG, Hodemaekers HM, Nagarajah B, et al., Association of vitamin D receptor polymorphism with susceptibility to symptomatic pertussis. PLoS One. 2016; 11:1-13. https://doi.org/10.1371/journal.,pone.0149576. PMid:26894582 PMCid:PMC4760950.
- Dabirnia R, Mahmazi S, Taromchi A, et al., The relationship between Vitamin D Receptor (VDR) polymorphism and the occurrence of osteoporosis in menopausal Iranian women. Clin Cases Miner Bone Metab. 2017; 13(3):190-94. https://doi.org/10.11138/ccmbm/2016.13.3.190. PMid:28228780 PMCid:PMC5318170.
- Nelson DA, Vande Vord PJ, Wooley PH. Polymorphism in the vitamin D receptor gene and bone mass in African-American and white mothers and children: A preliminary report. Ann Rheum Dis. 2000; 59(8):626-630. https://doi.org/10.1136/ard.59.8.626. PMid:10913060 PMCid:PMC1753219.
- Zintzaras E, Rodopoulou P, Koukoulis GN, et al., BsmI, TaqI, ApaI and FokI polymorphisms in the Vitamin D Receptor (VDR) gene and the risk of osteoporosis: A meta-analysis. Dis Markers. 2006; 22:317-26. https://doi.org/10.1155/2006/921694. PMid:17264402 PMCid: PMC3851656.
- Marozik PM, Tamulaitiene M, Rudenka E, Alenka V. Association of Vitamin D Receptor gene variation with osteoporosis risk in Belarusian and Lithuanian postmenopausal women. Front Endocrinol. 2018; 9:305. https://doi.org/10.3389/fendo.2018.00305. PMid:29922235 PMCid:PMC5996071.
- Zhang Z-l, Zhao J-x, Meng X-w, et al., Association of polymorphisms of vitamin D receptor gene start codon and 3’-end region with bone mineral density in postmenopausal women. Chinese J Med Gen. 2003; 20:5-8.
- Jia F, Wang D. Vitamin D Receptor Bsm I polymorphism and osteoporosis. Genet Test Mol Biomarkers. 2013; 17:30-34. https://doi.org/10.1089/gtmb.2012.0267. PMid:23134477.
- Liao J, Qin Q, Zhou Y et al., Vitamin D receptor Bsm I polymorphism and osteoporosis risk in postmenopausal women: A meta-analysis from 42 studies. Genes Nutr. 2020; 15: 20. https://doi.org/10.1186/s12263-020-00679-9. PMid:33238893 PMCid:PMC7687795.
- Garrofe RF, Fornes CG, Montane MB, et al., Polymorphism of Vitamin D receptor gene, bone mass, and bone turnover among women with postmenopausal osteoporosis. Rev Clin Esp. 2000; 200:198-02.
- Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer. 2001; 85:171-75. https://doi.org/10.1054/bjoc.2001.1864. PMid:11461072 PMCid:PMC2364044.
- Chen WY, Bertone-johnson ER, Hunter DJ, et al., Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarker Prev. 2008; 14:2335-40. https://doi.org/10.1158/1055-9965.EPI-05-0283. PMid:16214913.
- Trabert B, Malone KE, Daling JR et al., Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res. 2007; 9:1-10. https://doi.org/10.1186/bcr1833. PMid:18067661 PMCid:PMC2246187.
- Zhang K, Song L. Association between vitamin D receptor gene polymorphisms and breast cancer risk: A meta-analysis of 39 Studies. PLoS One. 2014;9(4). https://doi.org/10.1371/journal.,pone.0096125. PMid:24769568 PMCid:PMC4000223.
- Ntais C, Polycarpou A, Ioannidis JPA. Vitamin D receptor gene polymorphisms and risk of prostate cancer: A meta-analysis. Cancer Epidemiol Biomarker Prev. 2003; 12:1395-02.
- Berndt SI, Dodson JL, Huang W, Nicodemus KK. Gene polymorphisms and prostate cancer risk. J Urol. 2006; 175:1613-23 https://doi.org/10.1016/S0022-5347(05)00958-4.
- Shen Y. Polymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: A meta-analysis. Onco Targets Ther. 2016; 9:1033-45. https://doi.org/10.2147/OTT.S99428. PMid:27042096 PMCid:PMC4780196.
- Liu Y, Li C, Chen P, et al., Polymorphisms in the Vitamin D Receptor (VDR) and the risk of ovarian cancer: A meta-analysis. PLoS One. 2013; 8:1-8. https://doi.org/10.1371/journal.,pone.0066716. PMid:23826116 PMCid:PMC3691226.
- Tamez S, Norizoe C, Ochiai K, et al., Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer. 2009; 101:1957-60. https://doi.org/10.1038/sj.bjc.6605414. PMid:19904266 PMCid: PMC2777264.
- Mohapatra S, Saxena A, Gandhi G, et al., Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population. J Ovarian Res. 2013; 6:2-7. https://doi.org/10.1186/1757-2215-6-37. PMid:23705897 PMCid:PMC3668239.
- Pan Z, Chen M, Hu X, et al., Associations between VDR gene polymorphisms and colorectal cancer susceptibility: An updated meta-analysis based on 39 case-control studies. Oncotarget. 2018; 9:13068-76. https://doi.org/10.18632/oncotarget.23964. PMid:29560132 PMCid:PMC5849196.
- Bai YH, Lu H, Hong D, et al., Vitamin D receptor gene polymorphisms and colorectal cancer risk: A systematic meta-analysis. World J Gastroenterol. 2012; 18:1672-79. https://doi.org/10.3748/wjg.v18.i14.1672. PMid:22529698 PMCid:PMC3325535.
- Tekand, Y., Toptas, B. Association of vitamin D receptor gene polymorphisms with colon cancer. Genet Test Mol Biomarkers. 2012; 16:1058-61. https://doi.org/10.1089/gtmb.2012.0044. PMid:22852885. 131. Zhao X-Z, Yang B-H, Yu G-H, et al., Polymorphisms in the Vitamin D Receptor (VDR) genes and skin cancer risk in European population: A meta-analysis. Arch Dermatol Res. 2014; 306(6):545-53. https://doi.org/10.1007/s00403-014-1464-8. PMid:24771013.
- Burns EM, Guroji P, Ahmad I, et al., Association of vitamin D receptor Polymorphisms with the risk of nonmelanoma skin cancer in adults. JAMA Dermatol. 2017; 153(10):983-89. https://doi.org/10.1001/jamadermatol.2017.1976. PMid:28832880 PMCid:PMC5710406.
- Santonocito C, Capizzi R, Concolino P, et al., Association between cutaneous melanoma, Breslow thickness and vitamin D receptor Bsm I polymorphism. Br J Dermatol. 2007; 156(2):277-82. https://doi.org/10.1111/j.1365-2133.2006.07620.x. PMid:17223867.
- Apaydın M, Beysel S, Eyerci N, et al., The VDR gene FokI polymorphism is associated with gestational diabetes mellitus in Turkish women. BMC Medical Genetics. 2019; 20:82. https://doi.org/10.1186/s12881-019-0820-0. PMid:31096931 PMCid:PMC6524275.
- Sarma D., Chauhan V. S., Saikia K. K., et al., Prevalence Pattern of key polymorphisms in the vitamin D receptor gene among patients of Type 2 diabetes mellitus in Northeast India. Indian J Endocr Metab. 2018; 22(2):229-35. https://doi.org/10.4103/ijem. IJEM_213_17. PMid:29911037 PM Cid:PMC5972480.
- Goulart LR, Ferreira FR, Goulart IMB. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. FEMS Immunol Med Microbiol. 2006; 48:91-98. https://doi. org/10.1111/j.1574-695X.2006.00128.x. PMid:16965356.
- Singh I, Lavania M, Pathak VK, et al., VDR polymorphism, gene expression and vitamin D levels in leprosy patients from North Indian population. PLoS Negl Trop Dis. 2018; 12:1-14. https://doi.org/10.1371/journal.,pntd.0006823. PMid:30481178 PMCid:PMC6286024.
- Neela VS, Suryadevara NC, Shinde VG, et al., Association of Taq I, Fok I and Apa I polymorphisms in Vitamin D Receptor (VDR) gene with leprosy. Hum Immunol. 2015; 76:402-05 . https://doi.org/10.1016/j.humimm.2015.04.002. PMid:25890006.
- Kang TJ, Jin SH, Yeum CE, et al., Vitamin D receptor gene Taq I, Bsm I and Fok I polymorphisms in Korean patients with tuberculosis. Immune Netw. 2011; 11:253-57. https://doi.org/10.4110/in.2011.11.5.253. PMid:22194708 PMCid:PMC3242999.
- Cao Y, Wang X, Cao Z, Cheng X. Vitamin D receptor gene FokI polymorphisms and tuberculosis susceptibility: A meta-analysis. Arch Med Sci. 2016; 12:1118-34. https://doi.org/10.5114/aoms.2016.60092. PMid:27695504 PMCid: PMC5016579.
- Panda S, Tiwari A, Luthra K, et al., Association of Fok1 VDR polymorphism with Vitamin D and its associated molecules in pulmonary tuberculosis patients and their household contacts. Sci. Rep. 2019; 9:1-10. https://doi.org/10.1038/s41598-019-51803-8. PMid:31649297 PMCid: PMC6813333.
- Leon Rodriguez DA, Carmona FD, González CI, Martin J. Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy. Sci. Rep. 2016; 6:1-6. https://doi.org/10.1038/srep31263. PMid:27502545 PMCid:PMC4977507.
- Oliveira LR, Carvalho TB, Santos RM, et al., Association of vitamin D3, VDR gene polymorphisms, and LL-37 with a clinical form of Chagas disease. Rev Soc Bras Med Trop. 2019; 52:1-10. https://doi.org/10.1590/0037-8682-0133-2019. PMid:31508781.
- Shabandoust H, Sharifi I, Raiesi O, et al., Serum 25-hydroxyvitamin D level and Vitamin D Receptor (VDR) polymorphisms in patients infected with Leishmania tropica: A case control study. J Parasit Dis. 2019; 44(1):40-48. https://doi.org/10.1007/s12639-019-01159-7. PMid: 32174704 PMCid:PMC7046910.
- Aslan S, Akil I, Aslan G, et al., Vitamin D receptor gene polymorphism in children with urinary tract infection. Pediatr Nephrol. 2012; 27:417-21. https://doi.org/10.1007/s00467-011-2000-0. PMid:21947233.
- Hassanein SI, Sleem HM, Gad MZ. Vitamin D receptor gene polymorphisms (TaqI and ApaI) in relation to 25-hydroxyvitamin D levels and coronary artery disease incidence. J Recept Signal Transduct Res. 2015; 35:391-95. https://doi.org/10.3109/1079989 3.2014.959593. PMid: 25224407.
- Marazuela M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020; 21: 495-07. https://doi.org/10.1007/s11154-020-09569-2. PMid:32643004 PMCid:PMC7343578.
- Greiller CL., Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015; 7:4240-70. https://doi.org/10.3390/nu7064240. PMid:26035247 PMCid:PMC4488782.
- Bilezikian JP, Bikle D, Hewison M, et al., Vitamin D and COVID-19. Eur J Endocrinol. 2020; 183:133-47. https://doi.org/10.1530/ EJE-20-0665. PMid:32755992.
- Martineau A, Jolliffe D, Hooper R, et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ. 2017; 356:6583 https://doi.org/10.1136/bmj.i6583. PMid:28202713 PMCid: PMC5310969.
- Mohan M, Cherian JJ., Sharma A. Exploring links between Vitamin D deficiency and covid-19. PLoS Pathog. 2020; 16(9):e1008874. https://doi.org/10.1371/journal.,ppat.1008874. PMid:32946517 PMCid:PMC7 500624.
- Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. 2020; 8:570. https://doi.org/10.1016/S2213-8587(20)30183-2.
- Hastie CE, Mackay DF, Ho F, et al., Vitamin D concentrations and COVID-19 infection in UK Biobank. Diab Metab Syndr. 2020; 14:561-65 https://doi.org/10.1016/j.dsx.2020.04.050. PMid:32413819 PMCid:PMC7204679.
- Annweiler C, Hanotte B, de l’Eprevier CG, et al., Vitamin D and survival in COVID-19 patients: A quasi-experimental study. J Steroid Biochem Mol Biol. 2020; 204:1-6 . https://doi.org/10.1016/j.jsbmb.2020.105771. PMid:33065275 PMCid:PMC7553119.
- Jolliffe DA, Greiller CL, Mein CA, et al., Vitamin D receptor genotype influences risk of upper respiratory infection. Br J Nutr. 2018; 120:881-90. https://doi.org/10.1017/S000711451800209X. PMid:30132432.
- Grant WB, Lahore H, McDonnell SL, et al., Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and deaths. Nutrients. 2020; 12:1-19. https://doi.org/10.20944/preprints202003.0235.v2.
- Radujkovic A, Hippchen T, Tiwari-Heckler S, et al., Vitamin D deficiency and outcome of COVID-19 patients. Nutrients. 2020; 12(9):2757. https://doi.org/10.3390/nu12092757. PMid:32927735 PMCid:PMC7551780.
- Panfili FM, Roversi M, D’argenio P, et al., Possible role of vitamin D in Covid-19 infection in pediatric population. J Endocrinol Invest. 2021; 44:27-35. https://doi.org/10.1007/s40618-020-01327-0. PMid:32557271 PMCid:PMC7299247.